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Prescription drug advertisements are commonly seen in magazines and on
television, and as a result, the public is familiar with them. Many drug ads are targeted
toward older adults, who tend to use more medications, because they suffer from more
chronic conditions than younger adults. Nonetheless, the effectiveness of drug advertising
at persuading older adults to ask physicians for specific medications remains uncertain.
Older adults’ explicit memory for drug ads is poor, but their implicit memory for drug
ads may be better. Therefore, older adults may be implicitly persuaded by drug ads even
when they cannot explicitly remember seeing them.
The current study measured implicit memory with an incidental ratings exercise
and an indirect test of preference; explicit memory was measured with intentional
studying and a direct test of recognition. The purposes of the study were to compare
implicit and explicit memory for drug ads in older and younger adults, to determine
whether age differences in memory are affected by salient information or anxiety, and to

demonstrate that a test of implicit memory may be useful in estimating advertising
effectiveness.
The results showed no age difference for implicit memory for drug ads, but an age
difference was found for explicit memory for drug ads. However, contrary to hypotheses,
neither salient information nor anxiety had an effect on implicit or explicit memory. The
results were consistent with previous research demonstrating implicit memory in the
absence of explicit memory. Although older adults had slightly worse explicit memory,
both implicit and explicit memory for drug ads was generally good in both groups.
The results were also obtained within the everyday context of prescription drug
advertising, which extends memory research to an important real-world setting. Ethical
considerations for research on aging and advertising are discussed. Drug ads are designed
to be persuasive, but ads should be carefully designed to inform consumers, rather than to
manipulate them. The implicit memory manipulation succeeded in demonstrating that ads
are persuasive, suggesting that a complete assessment of advertising effectiveness should
include a test of implicit memory.
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CHAPTER I
INTRODUCTION

Prescription drug advertisements are frequently encountered in everyday media
and, in fact, they are among the most common types of ads in magazines and on
television. As a result, people are exposed to drug ads almost daily, and many have
become accustomed to seeing them and are familiar with them. Such familiarity is
evidenced by the escalating amounts of money spent annually on these ads and the
increasing numbers of them selling to the public (Kaphingst, DeJong, Rudd, & Daltroy,
2004; Kaphingst, Rudd, DeJong, & Daltroy, 2004).
One set of these advertisements focuses on both prescription and over-the-counter
medications. Multiple alternative medications appear to be available for every condition
and circumstance. Many of the drug ads are targeted toward older adults (Bell, Kravitz, &
Wilkes, 1999; Lipsky & Taylor, 1997), because this group is perceived to be more likely
to use prescription drugs. However, not much is known about the impact of drug ads on
older adults and, in particular, how memorable they are.
Older adults commonly experience a decline in various cognitive abilities,
including memory performance (Craik, 1994; Hess, 2005; Salthouse, 2004). Previous
research has indicated that older adults have poorer explicit memory for prescription drug
advertisements than younger adults (Abernathy & Adams-Price, 2006). However, little is
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known about older adults’ implicit memory for drug ads. Implicit memory is exhibited
when older adults have a favorable response toward drug ads even though they do not
remember seeing them. If older adults’ explicit memory for drug ads is poor but their
implicit memory for ads is relatively good, it may suggest that advertisers are partially
successful in getting their messages across to older adults. That is, drug ads may be better
remembered and therefore, more effective, than some direct memory measures have
indicated. Thus, some indirect memory measures may be needed in order to assess more
fully memory for and the effectiveness of drug ads.
Older adults’ memory for prescription drug advertisements is at present a matter
of theoretical and practical importance for a couple of reasons. First, memory
performance generally declines in older adults, and second, medication use by this group
is commonplace and increasing. The primary purpose of the current study was to examine
implicit and explicit memory for drug ads in both younger and older adults. A secondary
purpose of the study was to explore differences in both types of memory for drug ads in
both groups that may relate to other factors of interest, such as exposure to salient
information and level of anxiety. The study also provides additional information and
detail about the types of memory used in remembering such ads, and the relationship
between aging, types of memory for ads, and the ads’ overall effectiveness. In addition,
the study expands our understanding of implicit and explicit memory within the
contemporary, yet meaningful, everyday context of drug advertising.
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Prescription Drug Advertising

History and Description
The study of factors related to measuring the effectiveness of advertising for
products and services has been a popular area of research in business-related fields.
However, advertising for prescription drugs is relatively new to the marketplace, and
research on its effectiveness is limited. In particular, an interest in advertising
effectiveness is important because drug ads are specifically targeting an increasingly
growing segment of the population, older adults, whose ability to remember the ads may
be limited by memory decline. Thus, an examination of the effectiveness of drug ads in
older adults is needed.
Pharmaceutical drug companies continue to spend growing amounts of money
promoting their products to older adults through advertising (Kaphingst, DeJong et al.,
2004; Kaphingst, Rudd et al., 2004). The advertising, in turn, is supposed to increase
awareness of the drugs and demand for them. Therefore, this research area is a topic of
importance and interest to companies who heavily promote the drugs.
Prescription drug advertisements are presented through various forms of media
communication, but magazine and television ads seem to be the most common techniques
for drug advertising (Findlay, 2001). Magazine ads can be examined by consumers at
their own pace, making it possible (and likely) for the consumers to pay more attention to
the ads that are relevant to them, and less attention to the ads that are not relevant.
Television ads, by contrast, only provide a limited window of exposure to consumers, and
that makes paying attention to the ads more complicated.
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Pharmaceutical companies have long placed colorful prescription drug
advertisements in medical journals in order to promote and sell their products to
physicians and other medical personnel. However, in 1997 the Food and Drug
Administration (FDA) began permitting drug companies to increase their marketing
dramatically by allowing direct advertising of prescription drugs to potential consumers
in widely read magazines and on television. As a result of the change, the amount of
health-related information strategically presented and readily available to the general
public has grown exponentially (Morrow, Leirer, Andrassy, Hier, & Menard, 1998). In
particular, the number of prescription drug ads in magazines and on television has greatly
increased and advertising costs have reached into the billions (Bell, Kravitz et al., 1999,
2000; Bell, Wilkes, & Kravitz, 1999; “Direct-To-Consumer,” 2001; “Drug Firms,” 1999;
Findlay, 2001; Schommer, Doucette, & Mehta, 1998; Woloshin, Schwartz, Tremmel, &
Welch, 2001). The method of advertising is called direct-to-consumer-advertising
(DTCA).
A group that may be particularly affected by the increase in prescription drug
advertising is older adults. Three-quarters of all drug ads promote medications that treat
chronic health conditions (Bell, Kravitz et al., 1999), such as allergies, anxiety, arthritis,
cancer, cardiovascular disease, high cholesterol, and high blood pressure. Most chronic
health conditions are more common in older adults and as a result, many of the drug ads
target them (Bell, Kravitz et al.; Lipsky & Taylor, 1997). The DTCA strategy seems
logical and effective, because the elderly use more health-related resources than any other
segment of the population (Park, 1999). In addition, the vast majority of older adults
report having seen or heard drug ads, and one-third of older adults report having spoken
4

with their physician about a drug from an ad, with nearly all of them purchasing the drug
after the conversation (“Drug Firms,” 1999; Sumpradit, Fors, & McCormick, 2002).
Nonetheless, research concerning prescription drug advertising effectiveness for
older adults appears to be limited. To determine the effectiveness of drug ads for older
adults, implicit and explicit memory research is needed and is the focus of the current
study.

Direct-To-Consumer-Advertising and Consumer Response
The positives and negatives of DTCA of prescription drugs have been a matter of
debate (Hoek, Gendall, & Feetham, 2001; Jones & Mullan, 2006). On the positive side,
the method of advertising has encouraged potential patients to seek treatment for medical
conditions they were not aware could be easily treated. On the negative side, however,
the advertised drugs are often more expensive than less advertised, but equally effective,
alternative drugs (“Drug Firms,” 1999; Hoen, 1998). As a result, some have argued that
the prevalence and popularity of DTCA of drugs has driven up the cost of health care in
this country (“Arxcel Survey,” 2004; McGinley, 1999). Moreover, increased DTCA of
drugs has led to increased consumer demand for specific medications (“Drug Ads,” 2006;
Hoen). In fact, physicians report that patients request particular drugs they have seen
advertised (Bell, Wilkes et al., 1999). Therefore, DTCA appears to have intentionally or
unintentionally affected the physician-patient relationship (“Drug Ads;” Elliott, 1998;
Hoek et al.; Schommer et al., 1998; Sumpradit et al., 2002).
When patients see these colorful drug ads, designed to be eye catching, they are
frequently encouraged to ask their physicians about the drugs, and are at times inspired to
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request them, even when the drugs may not be best suited for their particular condition.
Furthermore, physicians report that patients who ask about and request specific drugs are
disappointed when they are not prescribed, potentially injuring the physician-patient
relationship. In some cases, the pressure to satisfy the patient may cause physicians to
prescribe drugs that are not in the patient’s best interest (Bell, Wilkes et al., 1999).
Patient disappointment and physician pressure complicate the DTCA approach.
Another problem with drug ads is that the information in them may be ambiguous,
overly simplistic, or only partially accurate. In addition, it has been suggested that drug
ads may mislead potential consumers about the safety, efficacy, and side effects of
specific medications. Both physicians and their patients have become concerned about
these issues (“Direct-To-Consumer,” 2001; Elliott, 1998; Hoen, 1998; Woloshin et al.,
2001). Note that the word “patient” easily could be replaced with the word “consumer.”

Prescription Drug Advertisements: Magazine Versus Television
As noted previously, prescription drug advertisements are frequently found in
magazines and on television. Although television drug ads are the most common form of
DTCA of prescription drugs (Brownfield, Bernhardt, Phan, Williams, & Parker, 2004),
they may not be the most appropriate mode for drug advertising. Television drug ads are
short, fast, and usually present only brief “sound bites” of information. Because older
adults process information more slowly than younger adults, the pace of presentation in
television ads may affect recall, with fast-paced ads being more difficult to remember
(Ensley & Pride, 1991; Stephens, 1982). In addition, most of the ads spend more time
providing information about the potential benefits, rather than the potential risks, of a
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drug. Advertisers also have found it difficult to describe side effects clearly and fully,
along with the attributes of a drug, in brief television ads (Kaphingst, DeJong et al., 2004;
Kopp & Bang, 2000).
As a result of these factors, television drug ads may be easy for consumers to
remember, but difficult to assess and evaluate, particularly concerning personal
relevance. The FDA has reduced the already limited amount of side effect information
required in television drug ads. Instead of listing possible side effects, advertisers can
now refer consumers to a drug-associated website that describes them in further detail
(Ingersoll & Ono, 1997; Kaphingst, Rudd et al., 2004). Unfortunately, no information is
available on how many consumers visit a website in order to learn more about the drug’s
benefits and risks.
Prescription drug advertisements in magazines may be a more effective form of
DTCA than drug ads on television. In contrast to television advertisers, magazine
advertisers have the opportunity to include more complete drug information, such as the
benefits and risks, in their ads. Thus, magazine ads are more likely than television ads to
include and describe more complete and extensive information about the drug’s benefits
and risks (“Direct-To-Consumer,” 2001). However, in order for additional information to
be effective, it should be simple to remember and understand (Morrow & Leirer, 1999).
An additional advantage of magazine drug ads is that they allow consumers ample time to
examine product information at their own pace. Accordingly, consumers can decide how
much or how little time to spend reviewing drug ads that interest them and may be
personally relevant. As a result, consumers would be expected to remember information
from magazine drug ads to which they pay close attention, especially when they consider
7

the ads personally relevant. Nonetheless, a disadvantage of magazine drug ads is that they
may not attract as much consumer attention as television drug ads, because they have
only a visual component and lack the complementary auditory component. Another
disadvantage of magazine ads is that consumers only see the ads if they subscribe to or
purchase magazines. In addition, the medication instructions provided to consumers can
be difficult to follow (Morrow & Leirer) and colorful magazine drug ads can be
somewhat ambiguous (Abernathy & Adams-Price, 2006), as can television drug ads. To
the extent that medication instructions and drug ads are confusing, their main points may
be difficult to remember and understand. The purpose of this study was to examine two
different types of memory for magazine-style drug ads in older and younger adults, and
to relate them to the concept of advertising effectiveness. Measuring memory within an
everyday context, such as prescription drug advertising, is consistent with the current
movement in memory research called everyday memory.
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CHAPTER II
IMPLICIT MEMORY

History and Description
The study of memory has been central to psychological research and can be traced
back to the work of Hermann Ebbinghaus (1850–1909). Ebbinghaus was the first
researcher to develop a systematic methodology for examining memory (Gathercole &
Collins, 1992; Masson & Graf, 1993; Roediger, 1990), and as a result, some consider him
the “father of memory.” Ebbinghaus’ concept of memory was broad, including both
conscious recollection and retention of past experiences without conscious awareness.
Ebbinghaus suggested that past experiences could be preserved without an awareness or
knowledge of having them (Masson & Graf; Roediger; Schacter, 1987). The study of
memory is fundamental to learning more about everyday cognitive functioning.
Throughout the history of psychology, the term “memory” has generally been
considered to reflect the conscious recall of information. In fact, most previous research
on memory has emphasized conscious forms of memory, rather than unconscious forms
(Graf & Schacter, 1985; Jacoby, 1991; Jacoby & Dallas, 1981; Jacoby & Witherspoon,
1982; Schacter, 1987). Therefore, conscious processes, rather than unconscious
processes, have been given greater attention in research. Memory has been defined in
many different ways, such as an ability, a process, or remembered information. This
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ambiguity adds to the confusion about what memory really is. In fact, there has been
ambiguousness surrounding the definition of memory from the beginning (Tulving,
1972). For a review of the history and various definitions of memory see Tulving (2000).
Memory theorists divide memory into many different categories, including the
commonly known short-term and long-term categories, but also into sensory,
primary/working, nondeclarative/declarative, procedural/semantic/episodic, and
prospective memory. Although divided by category, the memory concepts above are also
thought to be linked. The current study includes an account and examination of long-term
memory.
Long-term memory is the ability to store permanently vast amounts of
information and knowledge for lengthy periods of time. Thus, it has an unlimited
capacity and a relatively slow rate of forgetting. Additionally, long-term memory is such
an extensive category that it is commonly divided into subcategories. The primary
division of long-term memory centers on the declarative and nondeclarative distinction
(Kandel, Kupferman, & Iverson, 2000; Squire & Zola-Morgan, 1991). Declarative
memory involves conscious awareness, whereas nondeclarative memory does not involve
consciousness. Declarative memory is further subdivided into semantic and episodic
memory, which are examples of explicit memory. Nondeclarative memory is involves
procedural memory, which is an example of implicit memory. Therefore, the
declarative/nondeclarative memory distinction is similar to the explicit/implicit
distinction because memory that involves conscious or unconscious processing is called
explicit or implicit, respectively (Kandel et al.; Schacter & Tulving, 1994; Squire, 1994;
Squire & Zola-Morgan).
10

Explicit memory is conscious; it involves remembering with conscious awareness
and deliberate, intentional processes, and it has been studied since the start of memory
research (Graf & Masson, 1993; Graf & Schacter, 1985, 1987; Kihlstrom, 1987; Schacter
& Graf, 1986). The level of conscious awareness is heightened in an explicit memory
experiment, at both encoding and retrieval.
Implicit memory is unconscious; it involves remembering without conscious
awareness and deliberate, intentional processes. Interest in memory for unconscious
awareness dates back to the beginnings of psychology and implicit memory remains a
leading research topic within psychology (Graf & Masson, 1993; Schacter, 1987).
Research on implicit memory has increased noticeably in several subdisciplines of
psychology, including neuropsychology, cognitive psychology, and lifespandevelopmental psychology (Graf & Masson).
Implicit memory is also described as unconscious memory or memory without
awareness or deliberate processing. Implicit memory involves processing that can be
characterized in a variety of ways, such as automatic, passive, reflexive, unintentional,
and involuntary. Implicit memory is seen when there is improvement in task performance
as a result of previous exposure to or interaction with a stimulus (Graf & Schacter, 1985;
Kihlstrom, 1987; Schacter, 1987), even when a person cannot remember being exposed
to or interacting with the stimulus (Eich, 1984). Therefore, implicit memory functions
without knowledge of the previous learning situation (Graf, Squire, & Mandler, 1984). In
addition, implicit memory is said to influence decision making, such as when passive
exposure to a stimulus affects later perceptions of that stimulus (Graf & Masson, 1993).
In other words, preceding events and experiences influence and modify a person’s
11

behavior or response without that person having conscious access to memory (Squire,
1994; Squire & Zola-Morgan, 1991). Lack of conscious awareness in memory
performance or for memory of a situation is the key to distinguishing implicit memory
from explicit memory. An appropriate examination of implicit and explicit memory
involves particular measurement considerations and a review of those is next.
In practice, researchers distinguish implicit and explicit memory by noting
differences in the instructions and tests employed in a memory experiment. The
instructions involve the context of participants’ exposure to the stimuli that will later be
measured for memory. The tests determine whether or not participants’ attention is
directed back to the earlier stimuli exposure at the time of testing. The key difference
between implicit and explicit memory tasks is whether participants are instructed to
remember the target stimuli both during encoding and during retrieval.
Instructions can be intentional or incidental. Intentional instructions tell
participants to study and memorize the material presented to them because they will be
tested for it at a later time. Incidental instructions have participants perform a task
involving the stimuli, such as a ratings exercise, without informing them to study and
memorize it. Intentional instructions inform participants that a memory test is coming. By
contrast, incidental instructions do not mention an upcoming test. As a result, participants
intentionally or incidentally process the material.
Tests can be direct or indirect. Direct tests refer back to the earlier stimulus
exposure and ask participants to recall or recognize that material. Indirect tests do not
refer back to the earlier stimulus exposure. Instead, they ask participants to engage in an
associated decision-making task requiring a preference or judgment. Direct tests remind
12

participants about the previous situation and by contrast, indirect tests do not. As a result,
participants’ memory for the stimuli exposure or material is measured directly or
indirectly.
Explicit memory, or conscious awareness, is measured when intentional
instructions and direct tests are used together. Implicit memory, or unconscious
awareness, is measured when incidental instructions and indirect tests are used together.
Explicit and implicit memory were measured in the current study using the
instructions/test combinations described above. Although the combinations of intentional
instructions and indirect tests and incidental instructions and direct tests are sometimes
used to measure memory, they were not used in this study.
In explicit tasks participants are fully aware that a task directly measuring their
memory will follow exposure to a stimulus, so they attempt to learn the material.
Similarly, during the task they are fully aware that it is related to the earlier exposure, so
they refer back to the material. By contrast, in implicit tasks participants lack conscious
awareness or knowledge of the association between exposure to the target stimuli and the
task indirectly measuring their memory for the target stimuli. For example, Graf et al.
(1984) and Jacoby et al. (1993) exposed participants to a list of words and instructed
them to perform a ratings or reading exercise with the words. Participants did not expect
to see the words again. Later, however, participants were given word-stems, such as
MOT _ _, and asked to fill in the blanks with the first word that came to mind. If implicit
memory was functioning, participants tended to fill in the word-stems with a word from
the original list (e.g., MOTEL), when appropriate.
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The terminology used in experiments on implicit and explicit memory is
inconsistent in the literature and difficult to follow. Researchers have used various terms
to describe the same elements of an experiment, and overlap in use for the descriptive
concepts can lead to confusion among readers. To eliminate inconsistent terminology in
this study, the terms “incidental” and “intentional” will refer to instructions, “indirect”
and “direct” will refer to the test, and “implicit” and “explicit” will refer to the memory
types described above.
This terminology application does not appear to be consistent with any particular
study. However, Roediger, Weldon, Stadler, and Riegler (1992) referred to incidental and
intentional learning, Reingold and Merikle (1988), Merikle and Reingold (1991), and
Jacoby et al. (1993) referred to indirect and direct tests, and Graf and Schacter (1985,
1987) referred to implicit and explicit memory. The terms implicit and explicit also have
been used to describe both instructions and tests. For a full discussion and review of
memory-related terminology, see Johnson and Hasher (1987) and Richardson-Klavehn
and Bjork (1988).
The instructional type and testing measure used to measure implicit and explicit
memory are critically important and can lead to discrepant results when experimental
variations are used (Roediger et al., 1992). Therefore, implicit and explicit memory
studies with methodological differences may not produce comparable results. Studies that
appear to neither alternate the instructional and testing conditions nor use traditional
instructions and tests to measure implicit and explicit memory may not be similar to ones
that do. However, determining which procedure is most appropriate may be a challenge
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for future research. In addition, ensuring the separation of conscious and unconscious
influences in measures is difficult.
Implicit learning uses terminology similar to the terminology used in implicit
memory, and distinguishing one concept from the other concept can be difficult to do
because unconscious processes and processing are central to explaining them both.
During experimentation both implicit learning and implicit memory employ incidental
instructions (exposure to a stimulus without conscious awareness), but they differ in the
tests that are used to measure each. Implicit learning is usually measured with a direct test
(responding with conscious awareness of the exposure), whereas implicit memory is
typically measured with an indirect test (responding without conscious awareness of the
exposure). Therefore, when measuring implicit learning, participants are referred back to
the earlier presentation of the stimulus information in order to assist them in responding,
but they learn without conscious awareness of having done so during the exposure (Berry
& Dienes, 1991; Dienes & Fahey, 1998; Stadler, 1997). Thus, implicit learning and
implicit memory are the same during exposure, but distinct during testing. The current
study will focus on implicit memory, not on implicit learning.
An additional way to describe implicit memory is as the residual, persisting
influence an earlier exposure to stimuli has on later processing of the stimulus, such as in
a memory test, and especially when a person is not aware of the earlier exposure. The
availability of cues at both exposure and testing is a process commonly referred to as
“priming.” Priming is the facilitative effects an earlier learning episode has on later task
performance (Graf & Schacter, 1985; Tulving, Schacter, & Stark, 1982) and thus, is
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expected to improve memory. The manifestation of implicit memory can be thought of as
a form of priming (Yoo, 2008).
In earlier research, indirect tests of implicit memory were commonly referred to
as priming tests (Graf & Schacter, 1987). In fact, several studies cited as demonstrating
implicit memory are actually studies that established the effects of direct, item, and
repetition priming. For example, Graf and Schacter (1985, 1987), Light, Singh, and
Capps (1986), Sloman, Hayman, Ohta, Law, and Tulving (1988), and Tulving et al.
(1982) used priming to reveal implicit memory without referring to the effects of the
priming as implicit memory. Therefore, measuring priming has been considered as a test
of implicit memory because the earlier exposure to information affected later processing
for that information. In addition, elaborative encoding tasks for advertisements used as a
form of priming have been found to facilitate implicit memory for brand choice (Coates,
Butler, & Berry, 2004; 2006). Two widely held perspectives of implicit memory are
described next.
Tulving’s (1985a, b) separate systems model and Jacoby’s (1991) process
dissociation framework are two popular paradigms describing the influence of implicit
memory. Graf and Mandler’s (1984) activation view is another less popular, but notable
paradigm of implicit memory. Tulving proposed a memory model that consists of various
interrelated systems, such as episodic, semantic, and procedural, and the level of
consciousness is one method to differentiate the systems. For example, procedural
memory involves the lowest level of conscious awareness, which is none at all. As such,
implicit memory is involved in procedural memory. Jacoby, on the other hand, proposed
a memory framework that includes various processes, such as automatic and intentional.
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The influence of these processes during a task can be separated. In this example, implicit
memory or unconscious processing is involved when automatic processes are activated in
recognition memory. Graf and Mandler proposed a view of implicit memory evidenced
through priming effects that are the result of briefly activated knowledge representations
that already exist. Such activation occurs automatically without any elaborative
processing.
Tulving (1985a, b) did not develop implicit memory per se, but he hinted at its
presence when arguing for multiple memory systems and denoting the importance of
consciousness in separating the various systems. Additionally, level of consciousness is a
key component in distinguishing systems of memory.
The separate systems model has developed through the years from its original
episodic and semantic classifications (Tulving, 1972). Procedural memory was added to
the original dichotomy between episodic and semantic memory, and is separate from
them in the model (Tulving, 1985a, b). Procedural memory was also defined as implicit
memory. In addition, episodic memory cannot function without semantic memory just as
it cannot function without procedural memory. Nonetheless, procedural memory can
function separately from semantic memory, and it can function separately from episodic
memory. Although each memory system is distinct, each system also interacts and
engages with the other systems. Implicit memory is revealed through procedural memory
because it involves no consciousness (Tulving, 1985a, b). Tulving’s episodic-semantic
distinction has been criticized for lacking testable hypotheses and a specific theoretical
basis (McKoon, Ratcliff, & Dell, 1986), but it remains a seminal model for memory.
Recent additions to the model include perceptual representation and primary memory,
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with the former system contributing to an implicit memory effect. Although implicit
memory is not a memory system, it is an example of memory expressed without
conscious awareness through the procedural and perceptual representation memory
systems (Schacter & Tulving, 1994).
Jacoby (1991) did not name implicit memory per se, but he implied that it is
involved in the automatic processes of recognition memory tasks. Although intentional
processes are consciously controlled, require attention, and are used in recall, automatic
processes are faster, require less mental effort, and are involved in making familiarity
judgments.
The significance of the influence of automatic processes was shown in a series of
experiments that involved making judgments about famous and nonfamous names during
an inclusion/exclusion testing procedure (Jacoby, Kelley, Brown, & Jasechko, 1989;
Jacoby, Woloshyn, & Kelley, 1989). The experiments were designed to measure
automatic processes by providing multiple exposures of a name or dividing attention
during a familiarity test. The procedures either increased habituation or decreased
purposeful processes, depending on the condition. Jacoby and colleagues coined the term
“false fame effect” to describe the situation in which participants judged a nonfamous
name as famous because they had seen it before and were distracted during the test.
Similar results demonstrating the dissociation of automatic and intentional processes with
word lists also have been observed (Jacoby, Toth, & Yonelinas, 1993).
Examples of recognition memory, such as those noted, involved data-driven
processes and responses based on stimuli, whereas examples of recall involved conceptdriven processes and responses based on meaning. Thus, recognition and recall processes
18

are contingent upon different kinds of information. In short, Jacoby’s (1991; Jacoby,
Kelley et al., 1989; Jacoby et al., 1993; Jacoby, Woloshyn et al., 1989) research showed
that recognition or automaticity remained consistent even when recall or intentionality
varied because of repetition and distraction during recognition tasks. Additionally, Jacoby
noted the effects of intentional and automatic processes in both recognition memory and
recall. Jacoby suggested that recognition memory can be influenced by intentionality, and
recall can be influenced by automaticity. Therefore, the two processes are often used
collaboratively, but are functionally independent of one another. However, completely
separating conscious from unconscious influences in tasks can be challenging (Reingold
& Merikle, 1988). In addition, implicit memory studies have concluded that unconscious
processing influences conscious processing and that conscious awareness is not a
requirement for complex cognition (Kihlstrom, 1987).
When the words unconscious or automatic processes are used, respectively,
Tulving (1985a, b) and Jacoby (1991) are referring to the existence and impact of implicit
memory. In fact, automaticity is an indication of unconscious processes (Kihlstrom,
1987). The primary difference between these two paradigms is that Tulving promotes
implicit memory as an additional subsystem of memory that is instinctive, whereas
Jacoby promotes it as a distinct process of memory that is involuntary. Whether memory
is made up of multiple systems that work together or is a single system with various
processes that collaborate on the task represents an ongoing debate in memory research.
Another relevant debate in the literature is the debate about the experimental
appropriateness of studying everyday memory, which is memory performance in realworld contexts or settings (Gathercole & Collins, 1992). The goal of everyday memory
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research is research with a high level of ecological validity, or meaningfulness,
concerning day-to-day living applications. The study of everyday memory has
contributed to a more extensive understanding of memory applications beyond the
laboratory (Gathercole & Collins; Neisser, 1991). The debate began when Neisser (1978)
proposed that laboratory-based controlled experimentation had reached its limit and was
no longer making progressive scientific advances. Neisser (1978) charged researchers to
begin naturalistic studies of memory processes, and to become more concerned about
how such processes affect everyday life.
In criticism of Neisser’s (1978; 1991) proposal, Banaji and Crowder (1989; 1991)
suggested that although studying memory in naturalistic contexts or settings may appear
experimentally appropriate and have practical implications, it lacks an acceptable degree
of generalizability, which is an important objective in research. However, they also
admitted that their view has limited ecological validity, another important objective in
research.
The central debate centers on the level of experimental control as well as on the
use abstract versus everyday stimuli. Both matters have implications for the tradeoff
between ecological validity and generalizability; in fact, Banaji and Crowder (1989)
explored this tradeoff by reviewing various studies emphasizing one approach or the
other. On one hand, the everyday memory approach enhances ecological validity, but
diminishes generalizability. On the other hand, a laboratory-based approach improves
generalizability, but sacrifices ecological validity. Accordingly, ecological validity and
generalizability are best achieved in memory research when naturalistic and laboratory
perspectives are used together.
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The current study combined both of the research perspectives. In order to test
implicit and explicit memory, the study employed stimuli very similar to real prescription
drug advertisements, and the procedure took place in a controlled environment.
Therefore, the study had practical relevance to everyday living. In addition, because the
stimuli were properly pretested and pilot-tested, the influence of extraneous variables
should have been controlled. Taken together, the everyday stimuli and experimental
control enabled the study to establish ecological validity and achieve generalizability.
A fundamental attribute of implicit memory is that cognitive processes, which are
below conscious awareness, are influential in decision making. Thus, informal exposure
to an item affects a later action or response to that item. Because the exposure is informal,
people are typically unaware of how it may be affecting their response. Zajonc (1980,
2000) proposed that affect (feeling) may influence people’s preferences, attitudes,
impressions, and decisions (thinking) separately from conscious cognitive processing,
and that often affective judgments are made with more certainty and speed than cognitive
judgments. In summary, affective experiences are generated at the unconscious level
without cognitive engagement resulting in the separation of affect and cognition. This led
to a reconsideration of affect and its importance in decision making, and was called the
mere exposure effect.
The mere exposure effect is a phenomenon demonstrated when brief exposure to
an item increases subsequent liking for that item, even when a person cannot remember
being exposed to the item. The mere exposure effect is thought to be caused by the
tendency to become comfortable with items that are familiar; what may be surprising is
that only one exposure is needed for familiarity to occur.
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As such, the mere exposure effect is an excellent example of implicit memory. In
addition, the mere exposure effect illustrates implicit memory that is relevant to the goal
of persuasion in advertising. Advertisers aim to persuade consumers to like their
products, in the hope that they will eventually purchase them. A test aimed at measuring
explicit memory or conscious awareness for ads would be ineffective at measuring the
increasingly favorable emotional response successful ads should produce. However, the
capacity to assess advertising effectiveness at both the conscious and unconscious levels
allows researchers to more fully measure consumer responses to a product based on ad
exposure. To that end, it makes sense to assess advertising effectiveness using a test that
measures implicit memory or unconscious processing (Goode, 2007; Krishnan &
Shapiro, 1996; Shapiro, MacInnis, Heckler, & Perez, 1999). In support of that
recommendation, Goode suggested that a test of preference following exposure to ads is
in fact a test of implicit memory, and a significant and plausible way to measure
advertising effectiveness.
To a limited degree, advertisers have considered the impact prior exposure to an
item has on subsequent affect for it; however, explicit, rather than implicit, memory
measures were used in the studies. In summary, the implicit memory paradigm and its
associated measures provide another practical means to estimate consumer memory for
an advertisement, which assists in determining ad effectiveness, by evaluating affective
response to a product (Butler & Berry, 2001; Duke & Carlson, 1993; Finlay, Marmurek,
& Morton, 2005; Shapiro et al., 1999). Thus, implicit memory for advertising is one way
to demonstrate advertising effectiveness.
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Research Findings
Many researchers have examined the differences between implicit and explicit
memory (e.g., Graf & Schacter, 1985; Light et al., 1986; Tulving et al., 1982). Evidence
for differences between the two types of memory has come from various groups,
including brain-damaged adults with deficient functioning, cognitively intact adults with
normal functioning, and the elderly. In general, the three groups have shown stability and
instability in implicit and explicit memory, respectively.
Studies measuring implicit memory employ numerous tasks, such as word
completion (using stems or fragments), anagrams, object/perceptual/word identification,
picture naming, and lexical decision-making. Word-stem and -fragment tests are perhaps
the most popular measurements of implicit memory, and when compared with tests of
explicit memory, both tests have been found to capture unconscious processing from
studies of priming, elaboration, and forgetting (Roediger et al., 1992). By contrast,
studies measuring explicit memory commonly employ either free- or cued-recall or
recognition tasks. In addition, in implicit memory tasks, participants are unaware of an
earlier learning episode and are not encouraged to remember items from it. However, in
explicit memory tasks, they are aware of earlier learning and are encouraged to remember
(Graf & Schacter, 1987; Roediger, 1990; Schacter, 1987).
Early evidence on implicit memory came from neuropsychological research with
persons suffering from amnesia (Warrington & Weiskrantz, 1968, 1970). Amnesia is the
inability to retrieve old memories as well as create and form new memories. Persons
suffering from amnesia are at times affected by past experiences and events, even though
they cannot remember them. A classic example of the condition is that amnesics have to
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be reintroduced to people they have met because they have no memory of meeting them.
Although amnesics cannot remember meeting the people, the previous introduction will
probably shape how they respond to them. Thus, previous experiences and events,
although not consciously remembered, affect current responses. The early studies on
amnesia initiated a renewed interest in implicit memory that continues today (Roediger,
1990).
In seminal studies examining the retention of information in persons with
amnesia, Warrington and Weiskrantz (1968, 1970) found that similarities and differences
existed between the amnesic patients and patients without any memory deficits. In
contemporary terms, their studies demonstrated that the implicit memory of amnesic
patients is similar to control patients on indirect tests, such as picture- and wordcompletion tasks. However, the explicit memory of amnesic patients was found to be
markedly different from that of control patients on direct tests, such as recall and
recognition tasks. In summary, their studies showed that amnesic patients experience
deficits in explicit, but not implicit, memory tasks. The findings have been replicated by
researchers who have conducted experiments with amnesic patients with memory deficits
for a variety of neuropsychological reasons (Light & Singh, 1987; Light et al., 1986;
Roediger, 1990).
Amnesics usually have impaired memory for facts and episodes based on
declarative information, but intact memory for skills and procedures based on
nondeclarative information. Thus, amnesics usually perform well on a task measuring
procedural (implicit) memory, but have no episodic (explicit) memory of a previous
exercise or experience that primed or prepared them for the task (Kihlstrom, 1987).
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Comparable implicit and explicit memory performance has also been found in older
adults with Alzheimer’s disease, which produces cognitive deficits similar to amnesia and
results in physical and functional deterioration of the brain in older age. In particular,
although perceptual-motor learning was present in the patients, memory measured by
recall and recognition tests was absent (Eslinger & Damasio, 1986). Additional
neuropsychological research has found that people with various other visual, attentional,
recognition, reading, and comprehension deficits show evidence of implicit memory and
knowledge that cannot be expressed explicitly (Schacter, 1987).
Similar to the research on brain-damaged adults, studies have confirmed
differences between implicit and explicit memory in cognitively intact adults (e.g., Graf
& Mandler, 1984; Graf & Schacter, 1987). Evidence has been found for implicit memory
in the absence of explicit memory. Perhaps the most noted early study in normal adults
involves work on priming effects by Tulving et al. (1982). The researchers found
comparable memory performance on word-fragment and recognition tests after a 1-hour
delay. However, after a 7-day delay, the priming effects, as measured by the wordfragment test, were the same, whereas ability on the recognition test had diminished
considerably. The findings revealed the long-lasting and persisting effects of implicit
memory as opposed to the relatively temporal effects of explicit memory, even when
performance was similar at the outset.
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CHAPTER III
COGNITIVE AGING

Deficits and Theories
Cognitive aging is a popular specialty area in psychology, and it specifically
intersects the cognitive and developmental fields. Cognitive aging involves the study of
such mental abilities as memory, comprehension, decision-making, reasoning, and
perception in adults. The focus is on the elderly or those considered to be older adults,
who are usually close to retirement age or beyond. Cognitive aging is best examined
using a multidisciplinary approach (Hess, 2005; Salthouse, 1996). For a full discussion
and review of memory and aging see Light (1991, 1996) and Smith (1996).
Research has repeatedly shown that older adults typically show a range of
cognitive deficits, including memory deficits, when compared to younger adults in both
laboratory and ecologically valid tasks and situations. There are a number of cognitive
aging theories that address and explain the deficits. Processing efficiency is crucial, and a
person’s ability to process information effectively generally decreases as age increases
(Craik, 1994; Hess, 2005; Salthouse, 2004). Moreover, there is extensive empirical
evidence about cognitive aging, specifically memory deficits in the elderly.
For example, it is generally known that memory performance in the elderly tends
to decline when the task lacks environmental support, requires self-initiated, deliberate
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processing, or involves the integration of to-be-remembered material with contextual
information. Furthermore, additional memory declines will occur when the task requires
significant working memory demands, involves inhibiting irrelevant information, or is
based on perceptual and/or processing speed (Craik, 1994; Craik & McDowd, 1987;
Hess, 2005; Salthouse, 2004). Many memory tasks may involve more than one of the
preceding factors.
In addition, older adults are worse at recall than at recognition, perform more
poorly on working memory tasks than on simple storage tasks, and are worse on explicit
memory tasks than on implicit memory tasks. In fact, the performance of older adults on
recognition, simple storage, and implicit memory tasks in many instances is comparable
to younger adults (Craik, 1994; Craik & McDowd, 1987). Taken together, recall, working
memory, and explicit memory tasks all involve greater encoding and retrieval
requirements.
Further, the deficits are also related to the escalating limitations in an older adult’s
computational and/or attentional capacity (Craik, 1994; Craik & McDowd, 1987). The
memory problems older adults appear to experience with various tasks can be generally
explained and summarized by the complexity hypothesis (Cerella, Poon, & Williams,
1980), which proposes that memory performance declines more with age as the task
becomes more complex.
There are many theories of cognitive aging deficits. The self-initiated processing
hypothesis proposes that when older adults are involved in self-initiated or deliberate
processing, which requires a great deal of effort and is much less automatic, their
performance declines (Hasher & Zacks, 1979). The slowing hypothesis proposes that as
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we age, our ability to process information slows, based on processing speed and
perceptual speed (Birren, 1974; Salthouse, 1996). The working memory hypothesis
proposes that older adults experience challenges when the task involves simultaneously
processing and storing information (Salthouse, 1992; Salthouse & Babcock, 1991). The
research supporting the theories is consistent with finding larger age differences in
explicit than in implicit memory. The self-initiated processing theory is most relevant to
implicit memory because it predicts few age differences in memory that does not require
effort; implicit memory by definition requires no effort.

Research Findings
Similar to the research with brain-damaged and cognitively intact adults, various
studies focusing on memory and aging have verified differences in implicit and explicit
memory in the elderly (e.g., Light & Singh, 1987, Light et al., 1986). In particular,
between mentally and physically healthy older and younger adults, no performance
difference exists in implicit memory, but there is a difference in explicit memory.
One objective of cognitive aging research is to determine what functions remain
stable in older age and what functions become unstable. There is a normal cognitive
decline in older adults; however, the cognitive aging process does not appear to affect
implicit memory as much as it does explicit memory. In fact, a consistent pattern emerges
with older adult memory performance on tests of implicit and explicit memory. Although
older adults generally perform poorly on direct tests of explicit memory involving recall
and recognition, they perform as well as younger adults on indirect tests of implicit
memory involving word completion, identification, and decision-making (Graf, 1990;
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Light & Singh, 1987; Light et al., 1986; Mitchell, 1989). In summary, implicit memory
ability remains largely intact in older age, whereas explicit memory ability declines.
In an experimental replication of the Tulving et al. (1982) study, Light et al.
(1986) compared priming effects in older and younger adults. The researchers found an
age difference on the recognition test, with older adults doing worse, but comparable
performance on the word-fragment test between the groups immediately after the study.
However, after a 7-day delay, performance on both tests was worse for both groups, with
the most significant decline coming in the recognition test for older adults. In addition,
Light and Singh (1987) found similar results of priming effects in older and younger
adults. Age differences in performance were seen in free- and cued-recall and recognition
tests, but were not revealed in word completion and perceptual identification tests. Thus,
comparisons of older and younger adults have shown similar performance on tests of
implicit memory, but age differences on tests of explicit memory.
Equivalent results also have been obtained in additional research comparing
implicit and explicit memory in older and younger adults. For example, one study found
that older adults performed the same as younger adults on indirect tests of name
generation, but poorer on direct tests of name cued-recall. In addition, implicit memory
was unaffected by elaboration, whereas explicit memory was affected by it (Brooks,
Gardiner, Kaminska, & Beavis, 2001). Moreover, another study used various conceptual
and perceptual tests to measure implicit memory and found it to be stable across the lifespan, whereas age differences were found in free- and cued-recall tests used to measure
explicit memory (Mitchell & Bruss, 2003). Furthermore, O’Hanlon, Wilcox, and Kemper
(2001) used unrelated word pairs and word-stem completion tests to measure older
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adults’ ability for associative learning and found that they do not perform well on this
type of task because conscious processing is necessary.
Therefore, research has consistently shown no significant differences in implicit
memory between older and younger adults, but has shown differences in explicit memory
between the groups. As a result, this pattern of results suggests that memory ability on
indirect tests is preserved and retained in older adults, but memory ability on direct tests
is impaired (Graf, 1990). Because implicit memory is better than explicit in older adults,
the effectiveness of advertising, in general, and drug advertising, in particular, is likely to
be greater than previously thought.
The memory dissociations in implicit and explicit memory have been displayed
with numerous stimuli and in various groups. The empirical evidence in
neuropsychology, cognitive psychology, and life-span developmental psychology
indicates that implicit memory functions differently from explicit memory. In other
words, implicit memory appears to be present and available when explicit memory is
absent and unavailable.
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CHAPTER IV
ADVERTISING

Implicit and Explicit Memory for Advertising
In order for advertising to be effective, an element of persuasion is necessary.
Carl Hovland (1912–1961) was a noted psychologist in the area of persuasion, as it
applied it to personality and communication. His research is also applicable to advertising
effectiveness (Cox, 1961; Michael, 1960). Effective advertising that is persuasive can
produce one of two outcomes. First, it can prompt an instant response from a person or
second, it can influence a person’s perception of a product, and bring about a delayed
response. For example, after viewing an advertisement a person might immediately dial a
telephone number or enter a website address. An ad might also lead a person to develop
positive perceptions of a product, which would increase the likelihood that they would
purchase it later (Plassmann, Ambler, Braeutigam, & Kenning, 2007). Implicit memory is
demonstrated in the latter example, especially when a person is not consciously aware of
the earlier ad.
One way advertising can be persuasive is to change affect toward brands, which
should increase purchase intent for those brands. Purchase intent is used as a measure of
ad effectiveness and it is predicted by brand feeling. Advertising should enhance brand
salience, which is an increased likelihood of being aware of brands when making relevant
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purchasing decisions (Cramphorn, 2006). Therefore, advertising influences purchase
decision making through favorably changing affect.
Conventional models of advertising effectiveness have argued that memory plays
a central role in influencing consumer opinions about a product, and that ad effectiveness
should be measured by high recall of ad information. Recall demonstrates conscious
awareness of information, and awareness is seen as an indicator of ad success (Brown,
1985; Colman & Brown, 1983). Advertisers also commonly equate ad effectiveness
solely with explicit recall for ad information (Puntoni & Tavassoli, 2007). Goode (2007),
however, questions whether recall is an appropriate or complete measure of ad
effectiveness, suggesting that some aspects of advertising are not measured by explicit
recall.
Some traditional models of advertising involve hierarchical stages such as
Attention, Interest, Desire, and Action or Awareness, Knowledge, Liking, Preference,
Conviction, and Purchase (e.g., Huey, 1999). The early stages considered purchase
decision making to be conscious and intentional. However, the later stages include both a
thinking (conscious) component and a feeling (nonconscious) component, consistent with
the implicit/explicit distinction. In fact, the later models realized that an implicit
component should be included in advertising frameworks (Cramphorn, 2006; Huey).
Another aspect of advertising effectiveness, as reflected by contemporary
hierarchical models, is the creation or augmentation of positive brand feeling, also known
as brand equity. Brand equity is defined as the sum of all thoughts, feelings, perceptions,
and intentions toward brands, conscious or unconscious, which can be affected by
advertising. Therefore, one component of brand equity, which builds over time and may
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be a better predictor of ad effectiveness than conscious recall, is brand feeling
(Cramphorn, 2006; Plassmann et al., 2007).
Effective advertising is any advertising that enhances brand equity, which in the
long run, influences purchase decision making and buying behavior. An important
component of brand equity is affect; advertising should aim to elicit positive emotions
toward brands. Cramphorn (2006) suggests that advertisers need to understand how
advertising that makes emotions toward brands more positive are effective. In addition,
Plassmann et al. (2007) suggest that advertising that improves brand equity should lead to
higher sales over the long term, which is more important than sales over the short term.
Advertising may affect implicit and explicit memory differently, and a review of research
on implicit and explicit memory for advertising is next.
The majority of research on memory and advertising involves testing conscious
awareness of a product or service. In addition, most measures of advertising effectiveness
that advertisers use attempt to tap explicit memory (Holden & Vanhuele, 1999; Law &
Braun-LaTour, 2004; Shapiro & Krishnan, 2001; Perfect & Askew, 1994; Puntoni &
Tavassoli, 2007). For example, advertisers want to know if consumers can recall or
recognize an advertised product. However, some studies have directly examined explicit
and implicit memory for advertising.
Most of the studies on explicit memory for advertisements have found that it is
generally poor (Holden & Vanhuele, 1999; Krishnan & Shapiro, 1996; Shapiro &
Krishnan, 2001; Shapiro, MacInnis, & Heckler, 1997). In fact, there has been some
debate as to whether explicit tests of memory for advertising accurately assess ad
effectiveness (Holden & Vanhuele; Perfect & Askew, 1994). However, research has
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shown that many purchasing decisions tend to be made without having explicit memory
for a product (Finlay et al., 2005; Shapiro et al.), so the poor recall may not matter much.
Implicit memory may be more relevant to the assessment of advertising effectiveness.
Research on implicit memory and advertising involves testing unconscious
awareness for a product or service. Studies on implicit memory for advertisements have
found that it is in general robust (Holden & Vanhuele, 1999; Krishnan & Shapiro, 1996;
Shapiro & Krishnan, 2001; Shapiro et al., 1997). In fact, implicit tests of memory for
advertising have consistently shown more favorable and positive attitudes, judgments,
and preferences for ads that participants have been previously exposed to, regardless of
whether or not they can recall the ads (Perfect & Askew, 1994; Perfect & Edwards, 1998;
Perfect & Heatherley, 1997). In addition, implicit memory for a product may be more
closely linked to purchasing decisions than explicit memory (Cramphorn, 2006; Law &
Braun-LaTour, 2004; Shapiro & Krishnan). Thus, research has revealed implicit memory
in the absence of explicit memory, when testing memory for advertising information.
Research measuring explicit memory for advertisements has generally used
standard recall and recognition tasks (e.g., Finlay et al., 2005; Fung & Carstensen, 2003;
Krishnan & Shapiro, 1996; Shapiro & Krishnan, 2001; Shapiro et al., 1997; Stapel, 1998;
Perfect & Askew, 1994; Perfect & Heatherley, 1997). In addition, measurements of
implicit memory for ads have included preference ratings and judgments as well as
decision-making, listing, and word-stem completion tasks. For example, Perfect and
Askew (1994), Perfect and Heatherley (1997), and Fung and Carstensen (2003) asked
participants to rate ads on various factors such as them being perceived as likable,
memorable, distinctive, etc. Moreover, Shapiro and Krishnan (2001) had participants
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select brand names in a purchase decision-making exercise, Shapiro et al. (1997) had
participants list products for a specific buying situation, and Butler and Berry (2001) had
participants select the better label between pairs in a preference judgment task.
Furthermore, Krishnan and Shapiro (1996) and Finlay et al. (2005) asked participants to
complete word-stems for brand names and for previously seen words, respectively.
Repeated exposure and mere exposure effects also have been observed in some of the
implicit memory tasks from the studies above.
Indirect measures of implicit memory show that repeated exposure to
advertisements or simple repetition creates and increases positive feelings for brands
(Braun-LaTour & LaTour, 2004). In addition, repeated exposure to brands favorably
influences brand familiarity and therefore, improves the likelihood of those brands being
included during the purchase decision-making process, which gives them an advantage.
Exposure to old or new brands leads to an increased preference for those brands. In fact, a
single exposure to brands was found to be effective (Coates et al., 2004; 2006). This
process of responding positively to previously seen items is similar to what advertisers
expect to do when they introduce new brands (or drugs) through repeated exposure to
them in ads.
Advertisers who attempt to develop effective product advertisements should be
knowledgeable of research in psychology as well as in advertising. John Watson
(1878–1958), a renowned behaviorist, was one of the first to examine and document the
relationship between psychology and advertising, as both a researcher and practitioner.
His work is broadly recognized as influential in this area (Kreshel, 1990). In particular,
advertisers should be aware of the relationship between implicit and explicit memory and
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advertising effectiveness. A fuller understanding about the relationship will help
advertisers better evaluate which ads are and are not effective. Simply because consumers
cannot remember the exact name or a specific feature of a product noted in an ad does not
imply the ad was ineffective.
Research in both psychology and advertising has increasingly shown that learning
and persuasion about a product can occur without a person being aware of it (e.g.,
Grunert, 1996; Finlay et al., 2005; Perfect & Edwards, 1998; Perfect & Heatherley,
1997). Therefore, assessments of advertising effectiveness should include both the
implicit and explicit memory paradigm. Advertisers might also discover that they can
develop ads that activate both implicit and explicit memory for a product because a
combination of unconscious and conscious processes involving various levels of attention
is invariably involved in the perception of advertising (Grunert; Finlay et al.; Law &
Braun-LaTour, 2004; Shapiro & Krishnan, 2001). Because implicit and explicit memory
are used in processing drug advertisements, both processes should then be measured to
determine what information is remembered, consciously and unconsciously, from them.
Interestingly, Holden and Vanhuele (1999) replicated the “false fame effect”
coined by Jacoby and colleagues (e.g., Jacoby, Kelley et al., 1989; Jacoby, Woloshyn et
al., 1989) using brand names that appeared familiar because of previous exposure.
Moreover, Shapiro et al. (1999) refer to the usefulness of the process dissociation
framework when explaining a method to create and identify unconscious processing
within a marketing context. Furthermore, Goode (2007) cites the significance of
automatic processing, the “false fame effect,” and the process dissociation framework in
describing the relationship between implicit memory and advertising effectiveness. In
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short, measuring ad effectiveness only with direct tests of recall and recognition with
awareness may be a mistake, because this is only a partial assessment of ad success
(Holden & Vanhuele, 1999; Perfect & Askew, 1994; Perfect & Heatherley, 1997). An
additional, complementary measurement of ad effectiveness with indirect tests of
familiarity and preference without awareness should also be employed in order to address
the mistake.
In summary, an assessment of both implicit and explicit memory for advertising
may provide important information on the effectiveness of advertisements. Implicit
memory for advertising demonstrates that it has been effective even though consumers
are unaware of having seen it, whereas explicit memory for advertising demonstrates that
it has been effective because they are aware of it. The roles of implicit and explicit
memory during exposure to prescription drug advertisements are of particular interest in
the current study. Previous research connecting implicit and explicit memory for drug ads
in the elderly appears to be limited. Thus, an examination of implicit and explicit memory
for drug ads may provide some valuable information about ad effectiveness in an applied,
real-world context.

Prescription Drug Advertising and Older Adults
As noted earlier, many prescription drug advertisements are targeted toward older
adults (Bell, Kravitz et al., 1999; Lipsky & Taylor, 1997). However, even though older
adults are the primary target of drug ads, these ads may not always be developed with the
information-processing capabilities of the elderly in mind (Morrow et al., 1998). Also
noted earlier, older adults perform more poorly on a number of cognitive tasks compared
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to younger adults (Craik, 1994; Hess, 2005; Salthouse, 2004). For example, the
processing capability of older adults is limited when a task requires the initiation of
deliberate processing, the integration of contextual information with to-be-remembered
information, or the inhibition of irrelevant information. These capabilities may be
involved when the elderly reviews and evaluates drug ads. Advertisers should be aware
of the relationship between drug ad development and the processing capability of older
adults, in order to maximize ad effectiveness and minimize memory and comprehension
problems.
Research in both gerontology and marketing suggests that the usefulness of
prescription drug advertisements for informing consumers about drugs decreases as age
increases (Ensley & Pride, 1991). For example, Abernathy and Adams-Price (2006)
found that older adults were worse than younger adults at recalling the purpose of drugs
in magazine ads. Also, Schommer et al. (1998) found that older adults made more
mistakes than younger adults in recalling drug information in television ads. Finally,
Morrell, Park, and Poon (1989, 1990) found that older adults performed more poorly than
younger adults in recalling prescription label information. By contrast, Perri and Nelson
(1987) found that older adults were better than younger adults at recalling drug
information in magazine ads, when the medication in the ads targeted them. Therefore,
previous research on drug ad effectiveness in the elderly has produced mixed results, but
when the drug ads were relevant to them, they were more likely to remember it.
As noted previously, magazines constitute one of the most common formats for
prescription drug advertising. The format is both practical and logical because older
adults, particularly those who are affluent, read magazines more frequently than younger
38

adults (Burnett, 1991; Mehta & Purvis, 2003). In addition, older adults have more
positive attitudes toward drug ads in magazines than ads on television (Mehta & Purvis).
Therefore, advertisers may find that magazine drug ads are more believable, credible, and
closely attended to (and thus, more effective) than television ads, when promoting
prescription drugs to older adults. Again, additional advantages of magazine ads over
television ads for older adults include the fact that they can be conveniently examined at
a self-selected pace and that they can provide more comprehensive information than other
ad forms. Taken together, the advantages may make magazine ads easier to review,
understand, and remember, particularly when they are personally relevant.
Design issues, especially in colorful ads, constitute one potential problem with the
comprehension of magazine drug advertisements. Older adults may be at a disadvantage
in comprehending ads that are incompatible with their processing abilities. Many
magazine drug ads contain complex information and graphics that are difficult to
understand. For example, information is at times disconnected and details are randomly
displayed. In addition, the language used is complicated, and a considerable amount of
information is provided. Older adults have difficulty interpreting complex or crowded
visual fields (Sekuler, Bennett, & Mamelak, 2000). Moreover, older adults experience
problems fully understanding complex information (Adams-Price, 1993), such as medical
information about drug dosage and label instructions (Morrell et al., 1989, 1990; Park,
1999). Furthermore, understanding in older adults is hindered by illustrations, but
facilitated by better organization (Hartley, 1998; Morrell et al., 1990; Morrow et al.,
1998). Unfortunately, complicated wording and diagrams continue to be found in
magazine drug ads.
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In order to help maximize older adults’ comprehension, health-related web sites
should avoid designs with complex, multifaceted patterns or backgrounds (Echt, 2002).
Moreover, more information does not always result in better understanding, because
supplemental information without proper organization will probably add to
comprehension problems. As noted earlier, improved organization in magazine drug
advertisements may be especially helpful to older adults (Abernathy & Adams-Price,
2006; Morrow et al., 1998). Furthermore, a comparison of drug ads with some containing
more information and others containing less information found no memory differences
between the ads in older adults (Jones & Mullan, 2006). Thus, more information in ads is
not always helpful to the elderly.
Another potential problem with the comprehension of magazine drug
advertisements is that they may be ambiguous. Magazine drug ads are designed to
increase awareness of a drug and persuade consumers to try it. At times, ambiguous
catchphrases or slogans are intentionally used in order to capture attention and make the
drug ads memorable. As noted previously, ambiguity in ads is likely to worsen the
processing capacity of older adults to encode ad information (Byrd, 1988), which will
subsequently worsen recall for the information. As a result, ambiguity in magazine drug
ads may lead to more confusion than persuasion in older adults and diminish memory for
and comprehension of ad information.
Memory and comprehension are significantly correlated, central to cognitive
processing, and contribute to overall cognitive performance (Engle, Cantor, & Carullo,
1992; Just & Carpenter, 1992). Therefore, comprehension problems for magazine drug
advertisements will probably result in difficulty remembering them. Magazine drug ads
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that include complicated, distracting, or ambiguous information, details, or backgrounds
may be more difficult for older adults to remember and understand, even when the ads
are relevant to them.
Previous research has neither examined implicit and explicit memory for
prescription drug advertising nor extensively considered the ability of older adults to
remember information from this context. More research is needed to better understand
the relationship between aging and memory for drug advertising. In addition, advertising
that is emotional, as drug ads often are, tends to be preferred and better remembered by
older adults, which makes it particularly effective (Fung & Carstensen, 2003; Williams &
Drolet, 2005). The current study is valuable to researchers as well as advertisers who are
interested in how well older adults remember drug ads and how effective the ads are for
this group. Although research on aging, memory, and advertising as specific topics is
extensive, studies combining them are limited (e.g., Abernathy & Adams-Price, 2006;
Morris, Brinberg, Klimberg, Rivera, & Millstein, 1986).
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CHAPTER V
ADDITIONAL FACTORS

Salience
Salient information is information that is particularly pertinent to a circumstance
or situation. In addition, salient information may increase the attention paid to certain
drug advertisements and thus, improve memory for them. Moreover, salient items are
features of ads that are boldly presented, the center of attention, or repeated to capture
attention (Goode, 2007). Furthermore, the effect of pertinent information on implicit and
explicit memory can be significant because it enhances processing at exposure and
testing. In the current study, salient information was considered to be relevant or
meaningful medical information that was presented through the reading of vignettes
before the presentation of the prescription drug ads.
The salience manipulation is comparable to environmental support, because the
salient information provides a sense of personal relevance and familiarity during
exposure and testing. The presence of salient information or environmental support at
exposure and testing may improve memory, especially in older adults who experience
various memory-related deficits (Craik, 1986; Hess, 2005). Hulicka and Weiss (1965)
suggested that the memory performance of older adults is affected by the importance they
place on the memory task. Items that are important, or salient, to older adults may be
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more easily remembered than items that are less important, or less salient. As a result,
older adults may have better implicit and explicit memory for prescription drug
advertisements that treat the medical conditions that they are familiar with and aware of
than the drug ads that treat conditions unfamiliar and unaware to them. Older adults have
been found to recall drug information better than younger adults when the ads were
specific to them (Perri & Nelson, 1987). Therefore, the availability of salient information
may create a feeling of personal relevance and familiarity that may have a favorable
effect on memory.
Because older adults take more medications, prescription drug advertisements are
likely to be more salient to them than to younger adults. The facilitative effects of salient
information on memory may be more obvious in explicit tasks than in implicit tasks. In
addition, explicit memory may reflect salient items of an ad, whereas implicit memory
may reflect less salient items of an ad (Goode, 2007). Although little is known about the
potential effect salient information might have on implicit memory, it makes sense to
believe that the effect would be similar to that of explicit memory in adults, older and
younger. Anxiety may also affect implicit and explicit memory for drug ads, and a review
of research on anxiety is next.

Anxiety
Anxiety may negatively influence the cognitive abilities of older adults. Research
has indicated that anxiety experienced by older adults leads to poorer general cognitive
processing, especially memory performance (Andreoletti, Veratti, & Lachman, 2006;
Deptula, Singh, & Pomara, 1993; Hogan, 2003; Wetherell, Reynolds, Gatz, & Pedersen,
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2002). The State-Trait Anxiety Inventory (STAI) is a common assessment device used to
measure anxiety. The STAI measures both “state anxiety,” which reflects anxiety at the
moment, and “trait anxiety,” which reflects anxiety in general. Research on cognitive
performance in older adults has used the STAI mainly to assess the state component of
the measurement, although both components also have been measured (Andreoletti et al.;
Hogan; Wetherell et al.). Obtaining an assessment of anxiety before, during, or after
cognitive testing in older adults would be appropriate in research seeking to determine if
higher anxiety results in lower cognitive performance.
An inverse relationship has been established between state anxiety and memory in
older adults, specifically in explicit and working memory (Andreoletti et al., 2006;
Wetherell et al., 2002). Moreover, elevated anxiety levels have been related to poorer
performance on a complex divided attention task in older adults (Hogan, 2003).
However, the studies also found other measures of cognitive performance that did not
negatively correlate with anxiety in older adults. Furthermore, the studies did not
establish similar associations between anxiety and cognitive ability in younger adults
(Andreoletti et al.; Hogan; Wetherell et al.). In summary, although heightened anxiety
appears to have a harmful effect on cognitive performance in older adults, research
assessing state anxiety immediately after a memory test appears to be limited.
Additional factors that may contribute to the relationship between anxiety and
memory include metamemory and stereotype threat. Metamemory is a people’s ideas and
beliefs about their own memory abilities and about how memory operates and performs
(Dixon & Hultsch, 1983; Hertzog, Dixon, & Hultsch, 1990). The concept is significant
because it is based on the idea that memory beliefs commonly guide memory
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performance, particularly in older adults (Berry, West, & Dennehey, 1989). Older adults
have a tendency to be more concerned about their cognitive abilities, specifically
memory, and as a result they worry more, which results in anxiety (Andreoletti et al.,
2006; Wetherell et al., 2002). Older adults generally are less confident in their memory
ability than younger adults and believe that they are more likely to experience problems.
In fact, many older adults believe that memory problems as we age are unavoidable and
inevitable. Measurements of metamemory could also be described as measurements of
memory self-efficacy (Berry et al.; Dixon & Hultsch; Hertzog et al.; Lachman, 1991).
Stereotype threat is the tendency for people’s performance on tasks to be
consistent with common stereotypes of performance on those tasks by members of groups
to which individuals belong. Stereotype threat occurs when awareness that poor task
performance is expected on the basis of race, gender, or age leads to poorer performance
on tasks. Previous research has consistently observed heightened stereotype threat and
resultant substandard performance in women, African Americans, and older adults across
various tests and situations (Chasteen, Bhattacharyya, Horhota, Tam, & Hasher, 2005;
Hess, Auman, Colcombe, & Rahhal, 2003; Spencer, Steele, & Quinn, 1999; Steele, 1997;
Steele & Aronson, 1995). Moreover, stereotype threat is a form of self-fulfilling
prophecy, and it contributes to rising levels of anxiety (Osborne, 2007). Furthermore, to
the extent that older adults internalize the stereotype that they will have memory deficits,
their memory performance tends to be poorer when they are aware that their memory is
being tested.
Metamemory and stereotype threat appear to be importantly connected concepts.
Moreover, both concepts seem to contribute to the relationship between anxiety and
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cognitive performance in older adults. Furthermore, metamemory and stereotype threat
may affect the level of anxiety older adults experience during memory testing. Rahhal,
Hasher, and Colcombe (2001) appear to have effectively demonstrated the influence of
metamemory and stereotype threat. The study compared the performance of older and
younger adults on true-false trivia statements in two experiments. In the first condition,
during the learning and testing phases, a person’s memory or ability to remember was
emphasized in the instructions. In the second condition, the instructions did not include
any memory-related wording. Although age differences were observed when memory
was emphasized in the instructions, they were not seen when it was not included.
Similarly, Chasteen et al. (2005) showed that once stereotype threat has been activated, a
simple change in instructions is not sufficient to eliminate its detrimental effect.
Metamemory concerns and the presence of stereotype threat can cause elevated
levels of anxiety in older adults. Anxiety from being tested may be a partial explanation
for the poorer cognitive processing and memory performance commonly observed in
older adults. In summary, anxiety brings about cognitive interference in older adults
(Deptula et al., 1993; Osborne, 2007). In fact, the cognitive deficits in older adults may
appear larger than they actually are because of anxiety (Hogan, 2003). Because implicit
memory tests do not refer specifically to memory, they may be less likely to activate
stereotype threat and anxiety than explicit memory tests. Therefore, anxiety may be a
factor in explaining larger age deficits in explicit than in implicit memory.
Moreover, attempting to control for anxiety may cause cognitive deficits in the
elderly to diminish. Furthermore, the ability of older adults to develop effective strategies
to manage and reduce memory-related anxiety may minimize the cognitive deficits that
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are associated with it. Thus, the capacity to better cope with anxiety may also reduce
some cognitive decline in aging (Andreoletti et al., 2006). Although anxiety diminishes
the cognitive performance of older adults in the laboratory, little is known about the
influence of anxiety in everyday cognitive tasks. In other words, the same memoryrelated anxiety that potentially leads to cognitive deficits in older adults in experimental
settings may or may not be experienced in everyday life. The current study will address
the matter by using memory stimuli that are similar to stimuli encountered in everyday
life: prescription drug advertisements.

Current Study

Objectives
The primary objective in the current study was to examine implicit and explicit
memory for information presented in prescription drug advertisements in both older and
younger adults. The study explored the relationship between unconscious memory
(automatic processing) and conscious memory (deliberate processing) after exposure to
magazine-style prescription drug ads. Conscious awareness during exposure may not be
necessary in order for the ads to be effective. Do people have memory for ads even
though they do not remember seeing them? If they do, then advertising effectiveness may
be better than typically revealed by direct tests of explicit memory.
Advertising effectiveness is commonly measured by a person’s conscious abilities
to recall or recognize ad information after a delay. Such direct measurements assess a
person’s explicit memory of ads. However, measurements of a person’s unconscious
processes, such as familiarity or preference that may influence decision making after
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exposure to ads may be necessary in order to obtain a more complete estimate of ad
effectiveness. Such indirect measurements would assess a person’s implicit memory of
ads.
A secondary objective in the study was to examine the effect of a previous
presentation of salient information on implicit and explicit memory of advertisements in
both older and younger adults. Salient information was considered to be information that
is relevant to the ads. In other words, the study explored whether there are differences in
memory for the ads in the presence or absence of previously presented salient
information. In this case, salient information was presented in vignettes about people with
medical conditions that were also mentioned in the ads. The availability of salient
information may improve memory for ads. Do people have better memory for ads when
they have previously seen information relevant to them? If they do, then advertising
effectiveness may be enhanced when they have been exposed to information about the
medical condition being advertised before they see the ad.
It is possible that the presence of salient information in advertisements might
compensate for the comparatively pervasive cognitive decline in older adults, especially
concerning the conscious, deliberate processing involved in explicit memory tasks.
Therefore, the contextual and environmental support provided by salient information
could have a positive effect on explicit, as well as implicit, memory ability in older
adults.
An additional objective in the study was to examine the effect of the level of
anxiety on implicit and explicit memory of advertisements in both older and younger
adults. Anxiety has been shown to negatively impact cognitive performance, including
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memory, in adults. The study explored whether the level of anxiety negatively impacts
memory for the drug ads. Do people have better memory for ads when they have low
levels of anxiety? If they do, then advertising effectiveness may be improved when they
experience minimal anxiety during testing.
Older adults may be particularly susceptible to anxiety during testing situations as
a result of stereotype threat. Stereotype threat is when people’s performance on tasks is
affected negatively by their perception that they will perform poorly because they are
members of groups thought to be at a disadvantage on those tasks. For example, it is
widely believed that older adults perform worse than younger adults on memory tasks. As
a result, stereotype threat anxiety may affect the memory of older adults more than that of
younger adults. Therefore, high levels of anxiety could have a negative impact on
explicit, as well as implicit, memory ability in older adults. However, there is a greater
likelihood that explicit memory would be impacted in anxiety situations, because older
adults would be aware that their memory was being tested.
This study is important for a few reasons. First, prescription drug advertisements
may be more effective than an explicit memory task alone demonstrates. Second,
memory for drug ads may be better when a medical condition is more salient. Third, the
prevalence of drug advertising might reinforce the belief that brand name drugs are better
than generic alternative drugs.
Additional factors related to the objectives of the current study were also
assessed. The factors included intelligence, cognitive state, and evaluation judgments of
the advertisements. One or more of the factors may be correlated with implicit or explicit
memory in older or younger adults. The study’s various objectives should facilitate
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further understanding of the memory abilities of older and younger adults who
incidentally and intentionally examine prescription drug advertisements.

Research Questions
1. Are there differences between older and younger adults in implicit and explicit
memory for prescription drug advertisements and if so, what are the effect sizes
for the age deficit effects for implicit and explicit memory?
2. Does the presentation of salient or nonsalient information influence differences in
implicit and explicit memory in older and younger adults?
3. Is the level of state anxiety related to differences in implicit and explicit memory
in older and younger adults?

Hypotheses
1. There will be an age deficit effect in explicit memory, with older adults
functioning worse than younger adults, but not in implicit memory. Thus, the
effect sizes of the age deficit effects will be larger for explicit than for implicit
memory.
2. The presence of salient information will decrease the age deficit effect compared
to the presence of nonsalient information for explicit memory, but not for implicit
memory.
3. The level of state anxiety will be negatively correlated with explicit memory in
older adults, but not in younger adults, and will not be correlated with implicit
memory in either age group.
In review, the primary objective in the current study was to examine implicit and
explicit memory for prescription drug advertisements in older and younger adults. The
drug ads were modeled after actual ads used by pharmaceutical companies. The
secondary objective was to examine the effect of the presentation of salient information
on implicit and explicit memory for drug ads. An additional objective was to examine the
effect of state anxiety level on implicit and explicit memory for drug ads.
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The first research question centers on age differences in implicit and explicit
memory for drug advertisements in older and younger adults; are there age differences
and if so, how small or large are the differences? The second research question
concentrates on the impact of salient information on implicit and explicit memory for
drug ads in older and younger adults; does salient information influence age differences
in memory and if so, what is the extent of its effect? The third research question focuses
on the impact of state anxiety on implicit and explicit memory for drug ads in older and
younger adults; is state anxiety related to age differences in memory and if so, what is the
extent of its effect?
In response to the first research question, the hypothesis is that there will be an
age difference in explicit memory, with older adults performing worse, but not in implicit
memory. For the second research question, the hypothesis is that the presence of salient
information will decrease the age deficit in explicit memory. The hypothesis for the third
research question is that the level of state anxiety will be negatively correlated with the
explicit memory deficit in older adults.
The research questions and hypotheses refer to the probability that older and
younger consumers will implicitly and explicitly remember drug advertisements,
especially when memory is affected by salient information and anxiety, respectively. The
current study examined age differences (older and younger adults) in memory (implicit
and explicit) and the impact of both salient information and anxiety on memory using
fictitious, but extensively pretested stimuli that were created for the study.
The results of this study have facilitated a better understanding of the overall
relationship between age differences in implicit and explicit memory for drug
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advertisements. In addition, the effect of the presence or absence of relevant information
and anxiety on memory has been clarified. Finally, this study examined the value of
measuring implicit memory when examining advertising effectiveness.
Therefore, an overall purpose was to demonstrate and establish that a complete
assessment of advertising effectiveness should include indirect tests consistent with the
implicit memory paradigm. The effectiveness of advertisements, in general, and
prescription drug ads, in particular, can no longer be exclusively assessed by direct tests
measuring explicit memory. Doing so validates the erroneous suggestion that memory
can be tapped, in its entirety, with a single, direct test. Moreover, continuing to use a
direct test approach alone to measure explicit memory will lead to an incomplete and
thus, partial, assessment of ad effectiveness. The use of an indirect test to measure
implicit memory, in addition to a direct test, will provide a more complete assessment of
ad effectiveness (Krishnan & Shapiro, 1996). Furthermore, an indirect test will provide a
method to explore the mere exposure effect noted by Zajonc (1980). In addition, little is
known about the relationships between the mere exposure effect and drug advertising or
mere exposure and the elderly. This study has intersected cognitive, aging, and
advertising research in order to better address and answer these issues and questions.
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CHAPTER VI
METHOD

Participants
The participants in the current study were 80 older adults and 80 younger adults,
which produced two sample groups: older adults and younger adults. The responses of
one older adult participant were removed from all data analyses because of a low score
on the Mini-Mental State Examination (MMSE; Folstein, Folstein, & McHugh, 1975).
The sample size for both groups was large enough to detect or establish a medium effect
size at the .05 significance level, with an acceptable degree of statistical power at .80, in
order to compute a standard analysis of variance per the number of experimental
conditions and variables (Cohen, 1992). The age of 55 was strategically selected as the
minimum age for participants to be included in the older adult group rather than the more
traditional age of 60 or 65. The cutoff age was chosen because medication use at 55 is
similar to medication use at older ages, yet significantly higher than medication use at
younger ages (Davis & Heavner, 2002).
The majority of older adults were recruited from various churches, groups, and
organizations within the greater Starkville/Oktibbeha County (Mississippi) area. A few
older adults were recruited from another similar area in another comparable state
(Georgia), and their participation was completely voluntary. The younger adults were
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enrolled in General Psychology courses at a medium-sized research university, and their
participation was recruited through the Psychology Research Participation Program and
fulfilled course completion requirements. Data were first collected for the younger adults,
followed by the older adults, and the data collection process lasted approximately 2
months. The consent form can be found in Appendix A.
Both older and younger participants were equally likely to receive one of the four
experimental packets, labeled A, B, C, and D. The purpose of the four packets was to
present various orderings of the stimuli systematically, specifically the medical condition
vignettes and prescription drug advertisements, in order to avoid any ordering effects that
might impact the results. The various orderings were determined with a standard random
sequence generator procedure. Therefore, the stimuli in the packets were methodically
counterbalanced. Packets contained the same number of stimuli, vignettes and drug ads,
and followed the same general organization. Participants received one of the four
experimental packets, an identical data response packet, and followed the same
experimental sequence.
Information on demographic variables was collected in a demographic survey
from participants at the start of the study. The demographic information included age,
gender, ethnicity, education level, marital status, occupational status, number of years
lived at current residence, and town size. Older adults had a mean age of 68.34 (SD =
7.50), and the group consisted of 34 males and 45 females. Seventy-seven older adults
were Caucasian and two were African American. In terms of education level, 41 older
adults were college graduates with some postgraduate education.
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Younger adults had a mean age of 18.60 (SD = 0.89), and the group consisted of
30 males and 50 females. Sixty-three younger adults were Caucasian and 15 were African
American; there was also one Hispanic and one Asian participant in the sample group. In
terms of education level, all younger adults were high school graduates (or had received a
general equivalency diploma) and many reported completing some college. The
demographic survey can be found in Appendix B.
On the Shipley Vocabulary Test (SVT; Shipley, 1940), older adults scored 32.65
(SD = 3.54) and younger adults scored 27.86 (SD = 3.87). Also on the MMSE, older and
younger adults scored 28.30 (SD = 1.68) and 28.33 (SD = 1.46), respectively.
In addition, health-related information was collected in the Medical Conditions
Survey (MCS) that consisted of a general rating of health, the number of current chronic
health conditions, the number of current prescription medications taken, and the number
of serious illnesses that had been experienced in the last 5 years. On the health rating,
88.60% of older adults and 91.20% of younger adults rated their health as “good” or
“excellent.” On the additional health-related questions, older adults reported having an
average of 0.76 (SD = 1.21) chronic health conditions, taking an average of 3.71 (SD =
4.02) prescription medications, and experiencing an average of 0.35 (SD = 0.62) serious
illnesses in the last 5 years. Also, younger adults reported having 0.13 (SD = 0.33)
chronic health conditions, taking 0.60 (SD = 0.91) prescription medications, and
experiencing 0.06 (SD = 0.24) serious illnesses in the last 5 years. The MCS also
collected information about whether participants currently had or had experienced any of
the medical conditions noted in the stimuli. Older adults and younger adults reported
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experiencing 5.68 (SD = 3.49) and 3.15 (SD = 2.04) of the medical conditions,
respectively.

Overview
The current study measured implicit and explicit memory in older and younger
adults by employing medical-related stimuli, such as medical condition vignettes and
prescription drug advertisements. The research team that worked on the study developed
all original elements of the stimuli. In addition, the elements of the stimuli were
extensively pilot-tested and completely fictitious. The development and pilot-testing of
the stimuli occurred before the study’s main experiment. Additional information about
the effect of salient information and state anxiety on both types of memory in the two
sample groups was collected. Other information about intelligence, health, and evaluation
judgments that may potentially affect the assessment and evaluation of the study’s
various factors was collected, also.

Materials

Drug Names

Development of the drug names. The prescription drug names used were pilottested and fictitious. The development of the names took place in three different phases,
but the process of developing them was similar each time. On each occasion, an
aggregate list of names was compiled, the list was evaluated and narrowed, and a final
list was selected and used in the pilot-testing process. The drug names used in the pilot-
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testing process were selected on the basis of ecological face validity and collective
preference.
Initially, 16 drug names were selected by a psychology laboratory for use in a
familiarity check of a medical errors research project unrelated to the current study.
During the development of the current study, 16 additional drug names were selected.
Taken together, this preliminary set of 32 drug names was used and assessed during the
first part of the pilot testing. As the study expanded, more fictitious drug names were
selected. This additional set of 32 drug names was used and assessed during the second
part of the pilot testing. Thus, 64 drug names were used in both parts of the pilot-testing
process. The drug names were similar to other names commonly found in magazinebased, print prescription drug advertisements (e.g., number of letters and syllables,
prefixes and suffixes). The complete list of fictitious drug names can be found in
Appendix C.

Pilot-testing process for the drug names. The goal of pilot testing was to
determine and establish pairs of drug names that were equally likely to be preferred by
participants. Thus, participants would not be expected to prefer one drug name in a pair
more than the other because the names had been previously evaluated as equivalent. Pilot
testing enabled the researcher to find several pairings that could be used as stimuli in the
implicit and explicit memory tasks.
The pilot-testing process for the drug names involved two phases, which took
place on two different occasions. The same procedure was followed on both occasions.
The first phase of the pilot testing employed a ratings survey in order to narrow down the
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list of drug names to ones that were moderate in “appropriateness” or “suitability,” and to
remove any names that might be “inappropriate” or “unsuitable” as a result of poor (or
low) ratings. In this phase, pilot participants were given a list of drug names, and were
asked to rate them. The second phase employed preference surveys in order to narrow
down the pairs of drug names to those that were equally preferred by participants. In this
phase, participants were given pairs of drug names, and were asked either to choose
between them or to indicate “no preference.” Because the drug names were fictitious,
participants in the pilot testing would have had no prior familiarity or exposure to them.

First round of pilot testing. The first phase of the pilot testing in the first round
involved 27 students in an upper-level undergraduate psychology course who rated the
first set of 32 drug names on a 7-point Likert-style scale, with choices ranging from low
to high or from “poor name” to “excellent name.” The students were told that a marketing
firm was attempting to identify names for new prescription drugs, and they were asked to
rate the prospective names on the rating scale. The drug name ratings task used was the
same as described above, and in effect, was a measure of appeal or liking for the name.
The drug name ratings survey from the first round can be found in Appendix D.
An average rating for each drug name was then calculated, and the names were
paired according to their averages in a highest to lowest format. Therefore, the two drug
names with the highest averages were paired together and so on until the two drug names
with the lowest averages were paired together, resulting in 16 pairs.
The drug name pairings process enabled the researcher to arrange the drug name
pairings systemically for the surveys used in the second phase of the pilot testing. A total
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of eight surveys were developed for the second phase, with each consisting of 16 drug
name pairings (32 drug names). The 8 pairs from the 16 highest rated drug names and the
8 pairs from the 16 lowest rated drug names were used in the first survey. For the seven
additional surveys, the drug names were rotated within the high- and low-rated arranged
groupings in order to create new drug name pairings for each survey. Thus, the highest
and lowest rated drug names were always paired with other high- or low-rated names.
The second phase of the pilot testing in the first round involved 162 participants
in undergraduate psychology courses who reviewed each of the 16 drug name pairings in
one of the eight surveys and selected the name they preferred or considered to be the
“best name for a new drug.” Participants were General Psychology students, plus the
students from one upper-level psychology course. An average of 20 students (range from
17 to 23) completed each of the eight surveys. The students were told that a marketing
firm was attempting to identify names for new prescription drugs, and they were asked
either to choose the better name or to indicate “no preference.” The drug name preference
task used was the same as described above, and in effect, was a measure of choice
between the names. An example of the first drug name pairings preference survey can be
found in Appendix E. Taken together, 128 drug name pairings were evaluated in the eight
surveys.
From the first round of pilot testing, the first set of 10 drug name pairings (20
drug names) was selected and used in the study. The pairings were selected based on an
equal or nearly equal preference for each drug name in a pair and on chi-square values,
with high values indicating no significant differences for preference between the drug
names in each pair. All chi-square values for the selected drug name pairings were above
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0.600. Twelve drug names were eliminated from consideration after both phases of the
pilot testing, 4 because of poor (or low) ratings during the first phase of the pilot testing,
and 8 because they were not equally preferred with another name during the second
phase.

Second round of pilot testing. The first phase of the pilot testing in the second
round followed the same procedure as in the first round, except 37 students in two upperlevel undergraduate psychology courses rated the second set of 32 drug names. In
addition, the procedure was the same in the second phase of the pilot testing in the second
round, except 180 participants reviewed the 16 drug name pairings. Most participants
were again General Psychology students, but this time, students from two upper-level
psychology courses also participated. Finally, an average of 23 students (range from 20 to
27) completed each of the eight surveys.
From the second round of pilot testing, the second set of 10 drug name pairings
(20 drug names) was selected and used in the study. The pairings were selected through
the same process described in the first selection process. All chi-square values for the
selected drug name pairings were again above 0.600 in the second round. Twelve drug
names were again eliminated from consideration after both phases of the pilot testing,
using the same rationale for removal described in the first selection process.
The ratings survey and preference surveys used in both rounds of pilot testing
were comparable in format and style, except the drug names were different. Both sets of
the selected drug name pairings that were used in the study from the first and second
rounds, along with their chi-square values, are given in Appendix F. The students who
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participated in the pilot-testing process for the drug names did not participate in the
current study.

Drug Name Pairings and Medical Conditions Matching Process
Both sets of drug name pairings that were selected during the first and second
rounds of the pilot-testing process were next matched with two lists of medical
conditions. The first list consisted of 15 conditions more commonly experienced by older
adults, whereas the second list consisted of 15 conditions experienced equally by both
older and younger adults. The first set was matched with 10 conditions related to the
older adults, and the second set was matched with 10 medical conditions related to both
older and younger adults, resulting in two groupings (first set = older adults and second
set = older/younger adults). The development of the two lists of medical conditions and
the use of the five remaining conditions in each list is described below.
The arrangement of the drug name pairings was based on chi-square values
(highest to lowest), and the medical conditions were arranged alphabetically (A to Z).
The pairings and conditions were matched accordingly. The two groupings were then
interspersed, divided based on odd/even numberings, and alphabetized by medical
condition. This procedure resulted in two new groupings consisting of 10 drug name
pairing/medical condition combinations that included drug name pairings from both sets
and medical conditions from both lists. The first new grouping was used to measure
implicit memory, whereas the second new grouping was used to measure explicit
memory. Thus, the drug name pairings and medical conditions used in the stimuli were
specific to measuring one memory type or the other.
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The two new combination groupings were used in all experimental packets.
Therefore, both sets of drug name pairings and both lists of medical conditions were used
to measure implicit and explicit memory in all four experimental packets (A, B, C, and
D). The first drug name in each of the pairings was used in the prescription drug
advertisements in Packets A and B, whereas the second name was used in the drug ads in
Packets C and D. For example, the drug names Lynotine and Raloprox resulted in the
pairing that was combined with acid reflux (heartburn). Thus, Lynotine was used in
Packets A and B and Raloprox was used in Packets C and D, but both drug names were
used in the acid reflux ad in all packets. This arrangement enabled the researcher to
counterbalance the drug name pairings stimuli.
As a result, the 20 advertisements contained in all packets, 10 used to measure
implicit memory and 10 used to measure explicit memory, appeared identical, having
equivalent designs, except for different drug names used in the ads. In summary, 40
distinct drug names were used in 20 separate drug ads in order to develop four
experimental packets, with all packets consisting of 10 ads in each memory condition (20
total). The drug ads in Packets A and B had identical, twin ads in Packets C and D, but
with different drug names. Participants received one of the four experimental packets.
Because the selection of the drug name pairings was determined by student
responses, initially from rating scores and then from preference responses, it was believed
that the pairings were established by a systematic, yet randomized procedure.
Accordingly, employing the first drug name from each of the pairings in Packets A and B
and the second name in Packets C and D was thought to be experimentally sound,
because none of the paired names differed significantly in preference.
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Medical Condition Vignettes
The goal of the medical condition vignettes was to develop a brief narrative that
portrayed a realistic, yet emotional, scenario about a person experiencing or suffering
from a health-related condition. Thus, the vignettes were designed to elicit or evoke
emotion from participants in the study. Medical condition vignettes were used in all
experimental packets. All vignettes described a medical condition that could be treated
with a prescription drug. The vignettes were used as a salience manipulation in the study,
and they were presented to participants before any of the prescription drug
advertisements were presented.
In the packets, half of the medical conditions described in the vignettes
corresponded to the medical conditions noted in the drug ads, whereas the other half did
not correspond to any of the conditions noted in the ads. The vignettes with medical
conditions that corresponded to drug ads were labeled “salient,” whereas the other
vignettes were labeled “nonsalient.” For example, in one packet participants read
vignettes about acid reflux and acquired immune deficiency syndrome, but were exposed
later to drug ads about acid reflux and emphysema. In other words, the salient vignette
that described a narrative about acid reflux was followed by a drug ad about acid reflux.
However, the nonsalient vignette that described acquired immune deficiency syndrome
was not followed by a similar drug ad, but was instead followed by an emphysema drug
ad. This dissimilar drug ad noted a medical condition that had not been read about
previously. Therefore, the salient and nonsalient labels referred to whether or not the
vignettes provided relevant and related medical condition information that corresponded
to the drug ads clustered in the same memory condition.
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Development of the medical condition vignettes. The goal during the development
of the vignettes was to maintain as much experimental consistency as possible from one
vignette to the next. The researcher and his advisor developed 30 brief vignettes. The
medical conditions used in the vignettes were specific to measuring implicit or explicit
memory. All medical conditions in the vignettes came from the two lists of medical
conditions related to older adults and both older and younger adults noted above and
described further below. A general template was used in developing the vignettes, which
consisted of five sentences in paragraph form. Additionally, the vignettes were presented
in 12-point, regular, Times New Roman font.
From the general template, each of the five sentences had a specific purpose and
played a particular role in the vignettes. The first sentence introduced and named a
character or person. Both male and female names were used equally in the vignettes (15
each). The second sentence noted either the medical condition the character suffered from
or noted various adverse effects, limitations, or symptoms of the medical condition. The
third sentence also noted either the medical condition or the symptoms, depending on
which component of the information had been noted in the second sentence. The second
and third sentences rotated from one vignette to another. The selected symptoms of the
medical condition used in the vignettes originated from the Web MD internet website.
The fourth sentence stated the family’s emotional reaction or response to the character
suffering from the medical condition. A strategically selected emotional word was used
in the fourth sentence and how the word was chosen is described below. The fifth
sentence again mentioned the character’s name and made a concluding statement about
the present or future.
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In order to elicit or evoke emotion from participants in the study, strategically
selected emotional words were used to describe the family’s reaction or response to the
situation. The words were selected from the Affective Norms for English Words
(ANEW) report (Bradley & Lang, 1999). Using male and female participants, the report
established normative emotional ratings for more than 1,000 words across three
dimensions: pleasure, arousal, and dominance. The pleasure and arousal dimensions were
used to select emotional words for the study, whereas the dominance dimension was not
used.
The words in the ANEW report had been rated on the pleasure and arousal
dimensions with a 9-point scale. The researcher selected emotional words with average
ratings between 2 and 6 (ranging from unhappy to happy) for pleasure and between 4 and
8 (ranging from calm to excited) for arousal. Therefore, although the words were rated as
generally unpleasant and aroused, they were neither extremely unpleasant nor aroused.
Twenty emotional words were selected from the ANEW report and used in the vignettes.
A listing of the emotional words used in the vignettes and their pleasure and arousal
ratings can be found in Appendix G.
Readability of the medical condition vignettes also was carefully considered
during the development process. Vignettes were developed using standard readability
scores: the Flesch Reading Ease score (FRE; Flesch, 1948) and the Flesch-Kincaid Grade
Level score (FKGL; Kincaid, Fishburne, Rogers, & Chissom, 1975), in Microsoft Word
(version 2002). The FRE score rates text on a 100-point scale, and the higher the score,
the easier it is to understand the document. A standard document aims for a score of
approximately 60 to 70. The FKGL score rates text on a U.S. grade-school level, and a
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score of 8.0 means that an eighth grader can understand the document. A standard
document aims for a score of approximately 7.0 to 8.0. All vignettes developed and used
in this study had FRE scores ranging from 60 to 70 and FKGL scores ranging from 7.0 to
8.0, with average scores of 64.8 and 7.5, respectively. An example of the first set of the
medical condition vignettes from the implicit memory condition that was used in Packet
A can be found in Appendix H.

Organization of the medical condition vignettes. In the vignettes (30) and drug
ads (20), half of the medical conditions described in the vignettes and noted in the drug
ads pertained to older adults and half were related to both younger and older adults.
Although the medical conditions in the drug ads were the same in all packets, the medical
conditions in the vignettes varied partially from one packet to the next. As noted earlier,
half of the medical conditions described in the vignettes corresponded to medical
conditions in the drug ads, whereas the other half did not.
Packets consisted of two sets of 10 medical condition vignettes and two sets of 10
prescription drug advertisements. The sets of vignettes were partially the same and
partially different and, the sets of drug ads were the same, except for the drug names.
After reading the first set of vignettes and rating the first set of drug ads, participants’
implicit memory for the ads was tested with a drug name preference test. After reading
the second set of vignettes and studying the second set of ads, participants’ explicit
memory for the ads was tested with a drug name recall test. The full procedure is
described further below.
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In each of the memory conditions and from both sets of vignettes used in each
condition, five of the vignettes were salient items, whereas five were nonsalient items,
which created an experimental and control condition for the vignettes. As a result, 10
vignettes were salient and 10 were nonsalient. The nonsalient vignettes in the control
condition were the same in all experimental packets. However, the salient vignettes in the
experimental condition varied from one packet to the next. For example, the salient
vignettes that referenced the medical conditions–acid reflux, emphysema, glaucoma, and
allergies–were all found in different packets and different memory conditions.
In the implicit memory condition and both sets of vignettes specific to it, five
salient vignettes were used in Packets A and C, whereas another five salient vignettes
were used in Packets B and D. In the explicit memory condition and both sets of
vignettes specific to it, the same arrangement of salient vignettes was used in the packets.
Because the vignettes in the packets were partially the same and partially different, they
were initially arranged alphabetically (A to Z) by medical condition in the packets, then
rearranged by a random sequence generator. Thus, the orderings of the vignettes (salient
and nonsalient) in the packets were varied and counterbalanced.
The sentence in the salient vignettes that stated the family’s emotional reaction or
response to the character suffering from the medical condition was used interchangeably
in two vignettes. For example, the word “nervous” was used in both of the salient
vignettes about glaucoma and allergies. The exchange occurred to maintain consistency
from one vignette to the next, because one participant read a vignette about acid reflux in
a packet, whereas another participant read a vignette about emphysema in another packet.
However, the same sentence in the nonsalient vignettes was specific to the medical
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condition and was not used in another vignette. No exchange was necessary, because all
participants read the same nonsalient vignettes in all packets.
In summary, half of the vignettes in the packets were salient or nonsalient in that
they either did or did not provide relevant medical condition information that
corresponded to the drug ads clustered in the same memory condition. The vignettes
provided an additional experimental condition that measured the effect of salience on
both implicit and explicit memory.

Development of the Medical Conditions Lists
Initially, the researcher and his advisor compiled two extensive lists of common
medical conditions experienced by adults. The two lists were used to develop the
vignettes and drug ads stimuli. The first list was related specifically to medical conditions
more commonly experienced by older adults, whereas the second list was generally
related to medical conditions experienced equally by both older and younger adults.
An adult development and aging textbook and the WebMD internet website
assisted in creating the two lists (Papalia, Sterns, Feldman, & Camp, 2007). Both sources
provided valuable information about the related medical conditions included in the lists.
In addition, prior research on medical conditions targeted by prescription drug
advertisements confirmed the relative accuracy of the two lists (Bell et al., 2000; Bell,
Wilkes et al., 1999; Burak & Damico, 2000; Woloshin et al., 2001).
Next, the two lists were narrowed and final lists of 15 medical conditions each
were determined for both groups. The researcher and his advisor chose the final two lists
based on the conditions they considered to be most familiar to and associated with the
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particular groups. Of the 15 medical conditions included in each list, 10 were used in
both the vignettes and drug ads, whereas 5 were used only in the vignettes. The two lists
of medical conditions can be found in Appendix I. The older-age specific and general
medical conditions were evenly represented in the sets of vignettes and drug ads in all
experimental packets. Accordingly, half of the medical conditions in the sets of vignettes
and drug ads were related to older adults, and half of the medical conditions were related
to both older and younger adults.

Prescription Drug Advertisements
The goal of the prescription drug advertisements was to develop drug ads to use
as stimuli to measure implicit and explicit memory. The drug ads were considered
appropriate for measuring everyday memory in a real-world context. Implicit and explicit
memory was assessed by participants’ preferences for and recognition of drug names
noted in the drug ads. Although the drug ads were fictitious, the components or features
described below were considered information commonly found in such print ads.
Participants were told that the drug ads were “works in progress” and “potential ads,” in
order to explain why they might appear less complete or polished than actual ads.

Development of the prescription drug advertisements. The goal during the
development of the prescription drug advertisements was to maintain as much
experimental consistency as possible from one drug ad to the next. Using Microsoft
Office Publisher (version 2003), the research team created a total of 20 prescription drug
ads. The drug name pairings and medical conditions used in the drug ads were specific to
measuring implicit or explicit memory. Two versions of each ad were created, because
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two different drug names from the drug name pairings were used in the same ad. The
different versions appeared in different packets in order to counterbalance the drug
names. The first drug name from each of the pairings was used in Packets A and B, and
second drug name was used in Packets C and D. Other than the drug names, all other
components of the ad were identical.
The prescription drug advertisements were modeled after colorful ads that are
designed to be eye catching and are commonly found in popular magazines. The
researcher reviewed several colorful prescription drug ads from widely read magazines,
such as Southern Living, Time, and Newsweek, and noted the characteristics and design
layouts many of them have in common. The review process was performed in order to
give the drug ads an acceptable degree of ecological validity.
All prescription drug advertisements were created horizontally, in portrait
orientation similar to their presentation in a magazine, and two general models or formats
were selected and used as the layouts in their development. The first model included a
picture in the top half of the drug ad with a drug name, point of contact, and catchphrase
or slogan in the bottom half. The second model included a picture along the right side of
the drug ad with a drug name, point of contact, and catchphrase or slogan along the left
side. Twelve of the drug ads were developed from the first model, and 8 were developed
from the second model. In some drug ads, regardless of the model, the drug name and
point of contact was presented first with the catchphrase beneath them. However, in the
other drug ads the catchphrase was presented first with the drug name and point of
contact beneath it. All components of the drug ads were centered, with appropriate
margins.
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The background of the prescription drug advertisements was plain, because they
were printed on white paper. All pictures used in the drug ads were .jpg files and in color,
with the exception of one picture, which was black and white. In addition, about half of
the pictures included people, whereas the remaining pictures included objects. Although a
majority of the drug ads included one picture, a couple of ads included more than one
picture in order to present a “before and after” concept. The selected pictures were not
supposed to elicit or evoke any strong emotion from participants who saw them.
The drug names selected by the drug name development and pilot-testing process
described earlier were written in capital letters and ranged from seven to nine letters long.
Although a few contained either two or four syllables, the majority were three syllables
long. The drug names were also followed by a 16-point, bold font style registered
trademark symbol–®. The contact points were placed immediately below the drug names
in the drug ads and consisted of either a telephone number or a website address. The
telephone number was a 1-800 number followed by a general health-related word or
arrangement (e.g., 1-800-4DOCTOR). The website address was also a general healthrelated word or arrangement (e.g., http://www.safeway.com).
Neither the drug names nor the points of contact used in the advertisements bore
any relationship to the medical condition. In other words, both components of the drug
ads were neutral. The catchphrases in the drug ads were written in complete sentences,
including proper upper- and lower-case lettering and punctuation and were 8 to 12 words
long. In addition, each catchphrase noted the medical condition the drug treated but did
not begin with the condition. The catchphrases were basic, simple, and straightforward
statements; some were “proactive,” whereas others were “reactive.” In other words, some
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catchphrases centered on preventing a condition, whereas others focused on treating a
condition. The catchphrases were also developed and selected in order not to elicit or
evoke any strong emotion from participants who read them.
The drug name, point of contact, and catchphrase appeared in black text in the
drug ads. The two standard fonts of Times New Roman and Arial were used for all text in
bold style. The drug name and point of contact were presented in one font, whereas the
catchphrase was presented in the other font in the drug ads. The font used for the drug
name and point of contact and the font used for the catchphrase were rotated from one ad
to the next. The font sizes for the drug name, point of contact, and catchphrase were 48-,
24-, and 30-point, respectively. In a few instances, the font size for the drug name was
slightly reduced for formatting purposes. In summary, although the components of the
drug ads may have varied slightly, they were comparable in their design layouts. Five
sample prescription drug advertisements from the implicit memory condition that were
used in Packet A can be found in Appendix J.
In review, 40 prescription drug advertisements were used in the study (20 ads
with 2 versions each). The 20 ads used in Packets A and B included the first drug name
from each of the drug name pairings, whereas the 20 ads used in Packets C and D
included the second drug name. In other words, both versions of each ad were identical
except for the drug name. A set of 10 drug ads was presented to participants after a set of
10 medical condition vignettes in order to measure implicit memory, and 10 drug ads
were presented after 10 vignettes in order to measure explicit memory.
Therefore, memory was measured in two conditions at two different times, and
one set of drug ads and vignettes was used in each of the memory conditions. The
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medical conditions noted in the drug ads were the same in all packets. In addition, half of
the medical conditions noted in the drug ads were related to older adults and half were
related to both younger and older adults based on the drug name pairings and medical
conditions matching process described above. Half of the medical conditions noted in the
drug ads were also primed with previously read vignettes that provided relevant medical
condition information, whereas the other half of the medical conditions were not primed
with vignettes. The arrangement of the drug ads in the packets was determined by a
random sequence generator. Thus, the orderings of the drug ads were varied and
counterbalanced.

Drug Advertisement Ratings Survey
The purpose of the ratings survey was to expose participants to the prescription
drug advertisements in order to have them incidentally process the ads. A ratings survey
was thought to be an experimentally appropriate method to have participants process
information through incidental exposure. Therefore, the ratings survey was used in the
implicit memory condition, and the instructions for the survey were called incidental
instructions. Incidental instructions were used with the indirect test of memory, described
below, to measure implicit memory.
The researcher developed the ratings survey with a 5-point Likert-style scale for
participants’ responses. The survey instructed participants to rate the appropriateness of
the drug name for the medical condition noted in each drug ad. The survey responses
ranged from “not at all appropriate” (1), to “extremely appropriate” (5). A sample of the
drug advertisement ratings survey can be found in Appendix K.

73

Immediately before viewing the second set of prescription drug advertisements,
participants were given the intentional instructions, which exposed them to the drug ads
so that they would deliberately process the ads. Intentional instructions were thought to
be an experimentally appropriate method for having participants process information
through study and memorization. Therefore, the intentional instructions were used in the
explicit memory condition, and they directed participants to study the drug name and
associated medical condition noted in each drug ad for a later memory test. Intentional
instructions were used with the direct test of memory, described below, to measure
explicit memory.

Indirect Test of Memory
The indirect test of memory was used to measure implicit memory for the drug
names in the ads. The indirect test was used with the incidental instructions to rate the
drug ads to measure implicit memory. The same indirect test of memory was given to all
participants. The indirect test consisted of 10 drug name pairings, which included 1 drug
name from the set of 10 previously rated ads and 1 drug name that had not been seen.
Participants were instructed to circle the drug name they thought was better.
The same set of prescription drug advertisements was used in all experimental
packets in the implicit memory condition, except that the drug names in Packets A and B
were different from the drug names in Packets C and D, based on the drug name pairings.
The first drug name in each of the pairings was included in Packets A and B, whereas the
second name was included in Packets C and D. Thus, the drug names were
counterbalanced, with the result that participants were exposed to one of the drug names
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in the pairings during the ratings exercise, but not to the other drug names in the pairings.
For example, the drug names from Packets A and B, such as Lynotine and Marolfan,
were paired with the drug names from Packets C and D, such as Raloprox and Doyestin.
The drug name pairings on the indirect memory test were listed vertically and side by
side; however, the positioning of the paired drug names (first or second position) based
on which name had been rated was varied. The indirect test of memory can be found in
Appendix L.

Direct Test of Memory
The description of the direct test of memory is similar to the description of the
indirect test of memory, because the tests were developed identically and presented to
participants similarly in the data response packet. The direct test of memory was used to
measure explicit memory rather than implicit memory for the drug names in the ads. The
direct test was used with the intentional instructions to study the drug ads to measure
explicit memory. The same direct test of memory was given to all participants. The direct
test consisted of 10 drug name pairings, which included 1 drug name from the set of 10
previously studied ads and 1 drug name that had not been seen. Participants were
instructed to circle the drug name they remembered from the ads.
The same set of prescription drug ads was used in all experimental packets in the
explicit memory condition, except that the drug names in Packets A and B were different
from the drug names in Packets C and D. The first drug name in each of the pairings was
included in Packets A and B, whereas the second name was included in Packets C and D.
Thus, the drug names were counterbalanced, with the result that participants were
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exposed to one of the drug names in the pairings during the study and memorization
exercise, but not to the other drug names. For example, the drug names from Packets A
and B, such as Winoxyl and Kentadrin, were paired with the drug names from Packets C
and D, such as Pendian and Glenestex. The drug name pairings on the direct memory test
were listed vertically and side by side; however, the positioning of the paired drug names
(first or second position) based on which name had been studied was varied. The direct
test of memory can be found in Appendix M. Because of the high level of similarity
between the indirect and direct memory measures, they are comparable instruments.

Shipley Vocabulary Test
The SVT is a brief psychometric component of a measure commonly used to
assess cognitive or intellectual impairment and deterioration (Shipley, 1940). The SVT is
one part of a two-part self-administered scale. The other part of the scale is an abstract
thinking test, which was not used in the current study.
The SVT is a synonym test with multiple-choice style responses. The test consists
of 40 words or items each followed by four possible answers, and becomes increasingly
more difficult as it progresses. In order to make both parts of the SVT equally difficult in
this study, the first part included the odd items of the original SVT, whereas the second
part included the even items. The normative data for the complete scale was established
with children, adolescents, and young adults. The reliability alpha coefficients were .87
for the vocabulary part of the scale and .92 for both parts of the scale. Although the scale
was not designed to be an intelligence test, it is reasonable to conclude that both parts of
the scale are central to intellect. Therefore, the scale may be considered as an alternative
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assessment for intelligence (Shipley, 1940). The SVT was used in this study as an
indicator of crystallized intelligence and in order to ensure that the older and younger
adults were comparable groups. A sample of the SVT can be found in Appendix N.

State-Trait Anxiety Inventory
The State-Trait Anxiety Inventory (Form Y) (STAI; Spielberger, 1983) is a brief
psychometric measure commonly used to assess anxiety by indicating signs of distress,
uneasiness, fear, apprehension, and tension. The STAI is a popular assessment of anxiety
and has been broadly used in both research and clinical practice (Spielberger). The STAI
consists of two parts and 40 statements or items (20 in each part) followed by four
possible responses in multiple-choice style. About half of the items are phrased
positively, and scored reversed, accordingly.
The two parts measured in the inventory are “state anxiety” and “trait anxiety.”
State anxiety is situational anxiety, or anxiety at a particular time in response to a certain
situation. Moreover, it is a temporary or short-lived condition. Trait anxiety is pervasive
anxiety, or the propensity to experience anxiety across situations. Furthermore, it is a
more general or long-lasting condition. The S-Anxiety scale measures a person’s feelings
“right now, at this moment.” The state part also estimates current feelings of
apprehension, tension, nervousness, and worry about immediate physical danger and
psychological stress. The T-Anxiety scale measures a person’s feelings “generally.” The
trait part is also used as a device for screening and identifying people with anxiety
disorders (Spielberger, 1983).
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The normative data for the inventory was established with working adults, college
students, high school students, and military recruits. The STAI was found to be both
reliable and valid. The reliability alpha coefficients were .92 for the S-Anxiety scale and
.90 for the T-Anxiety scale (Spielberger, 1983). The STAI was used in this study to
measure anxiety in the older and younger adult groups for comparative purposes and to
observe the effect of anxiety on memory. A sample of the STAI can be found in
Appendix O.

Mini-Mental State Examination
The MMSE is a brief psychometric measure commonly used to assess the
competence, ability, and current mental status of adults. In addition, the MMSE assesses
level of cognitive functioning (high or low), degree of cognitive deficits or impairments,
and tracks cognitive decline or improvement over time (Folstein et al., 1975).
The MMSE has two parts and 11 questions: a verbal part that addresses
orientation, memory, and attention and a manual part that involves reading and writing.
The normative data for the exam was established with clinical patients with a range of
psychological conditions, and it was found to be both reliable and valid. The reliability
alpha coefficients were .89 with the same tester and .83 with different testers (Folstein et
al., 1975). The exam was used in this study to ensure that participants, especially older
adults, were cognitively high functioning and to indicate any signs of cognitive
performance deficits or impairments. Thus, both the MMSE and the SVT were used to
make certain that participants in the older adult group were competent and had no
indications of mental instability. A score below 24/30 on the MMSE indicates subpar
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performance and is indicative of cognitive impairment (McHugh & Folstein, 1979). A
sample of the MMSE can be found in Appendix P.

Medical Conditions Survey
The researcher and his advisor developed the MCS to collect health-related
information from participants. The survey was used in this study to collect information
about whether participants currently had or had experienced any of the medical
conditions (30 total) noted in the vignettes or drug ads stimuli. In addition, the survey
asked for a general rating of health, the number of current chronic health conditions, the
number of current prescription medications taken, and the number of serious illnesses a
person had had in the last 5 years. The chronic health conditions, prescription
medications, and serious illnesses were also listed in the survey. The MCS can be found
in Appendix Q.

Drug Advertisement Evaluation Judgments Survey
A drug advertisement Evaluation Judgments Survey (EJS) was designed to
measure attitudes toward drug advertisements. The survey was a combination of two
previously used scales that measured attitudes and feelings toward television ads.
The survey consists of 18 words or items followed by five possible responses in
multiple-choice style. Some of the items are reversible and are phrased and scored
accordingly. The normative data for the two scales was established with female
consumers, advertising practitioners, and participants recruited from announcements. The
reliability alpha coefficients ranged from .89 to .93 for the evaluation scales (Burke &
Edell, 1989; Edell & Burke, 1987; Whipple & Courtney, 1980).
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The survey was used in this study to gauge participants’ evaluations of the
prescription drug advertisements that were rated and studied in the experimental packets.
The drug ads were evaluated collectively by participants, rather than individually.
Collecting evaluation data was thought to be important, particularly because the drug ads
were fictitious. The drug advertisement EJS can be found in Appendix R.

Experimental Packet
Four experimental packets, labeled A, B, C, and D, were used in the study.
Packets were evenly distributed to all participants in both groups. Participants received
one of the four experimental packets, which consisted of a set of 10 vignettes, 5 on two
pages, followed by a set of 10 prescription drugs, 1 per page. The vignette/drug ad
arrangement was presented twice in all packets, and both sets of vignettes and ads were
presented in the same format. Thus, all experimental packets had two sets of vignettes
followed by two sets of drug ads, with a blank page separating the sets of vignettes and
drug ads.
The vignettes and drug ads were varied and counterbalanced in each of the
packets. As a result, participants received similarly organized, but distinctly arranged
experimental packets of vignettes and drug ads. As noted previously, half of the medical
conditions described in both sets of the vignettes were different (salient) and half of the
conditions were the same (nonsalient) in certain packets. Both sets of drug ads were
identical in all packets, except for the drug name, which was a different name in certain
packets. Salient vignettes were associated with one of the subsequent drug ads, whereas
nonsalient vignettes were not associated with any of the ads. The salience manipulation
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resulted in an experimental condition (salient) and control condition (nonsalient) in both
the implicit and explicit memory conditions.

Data Response Packet
Participants received an identical data response packet. The data response packet
was applicable to or valid for all experimental packets. Therefore, the data response
packet could be used with any of the experimental packets. However, the data response
packets were numbered per the experimental packet used in order to determine correct
answers (e.g., the response packets used with experimental packet A were numbered in
the 100s, experimental packet B were numbered in the 200s, and so on). The response
packet consisted of the demographic survey, drug ad ratings survey, first part of the SVT,
indirect test of memory, second part of the SVT, direct test of memory, STAI S-Anxiety
scale, STAI T-Anxiety scale, MCS, and drug ad EJS. The data response packet also
included instructions for each of the surveys, tests, and scales, except for the
demographic survey. Some instructions were presented on the page before the measures,
whereas other instructions were at the top of the same page as the measures. All materials
have been described in detail above.

Procedure
The study was a 2 x (2) mixed experimental design with one between-participants
variable and one within-participants variable. The between-participants variable was age
group (older vs. younger adults) and the within-participants variable was the salience
manipulation (salient vs. nonsalient) used to compare implicit and explicit memory. The
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implicit memory condition employed incidental instructions and an indirect test, and the
explicit memory condition employed intentional instructions and a direct test.
The memory test measures were the outcome variables of the study. Therefore,
the salience manipulation (salient/nonsalient) and memory condition (implicit/explicit)
were the independent variables and memory performance (proportion of preference and
recognition) was the dependent variable. All variables have been described in detail
above.
Participants, in both the older and younger adult groups, were exposed to the
same experimental conditions and followed the same experimental sequence. Participants
received one of the four experimental packets and a data response packet. The
experimental sessions were scheduled for two participants, and a different experimental
packet was given to each participant when the sessions actually included two participants.
At times, however, sessions were performed with a single participant. Participants were
given as much time as necessary to complete each part of the session, and this was
typically between 45 minutes and 1 hour. In some instances, the time needed to complete
the session was slightly longer than an hour, particularly for the older adults.
Data were collected first for the younger adults, followed by the older adults. The
experimental sessions for the younger adults were conducted in the Department of
Psychology in Magruder Hall on the Mississippi State University campus, whereas the
experimental sessions for the older adults were conducted at a local church in the two
states. All experimental sessions were conducted in a controlled, laboratory setting. Three
different experimenters conducted the sessions, and each experimenter followed the same
procedural guidelines or instructions in order to be as consistent as possible from one
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session to the next. The researcher conducted approximately half of the sessions, and the
remaining sessions were divided more or less equally between the other two
experimenters.
Participants were greeted as they entered the testing room, and the experimenter
introduced himself to them. Next, the experimenter encouraged participants to listen
carefully to the instructions so that they could respond appropriately to each part of the
packet. Participants were given two copies of the consent form and instructed to carefully
read one copy and sign it and to take the other copy with them when they left the testing
site. Participants were then given a randomly selected experimental packet and data
response packet.
Participants were asked initially to complete the demographic survey by writing
in and circling the appropriate responses. The demographic survey was the first page of
the data response packet. When two participants were in the same experimental session,
they were instructed to sit patiently and quietly if one participant completed a part of the
packet before the other participant completed it. Participants were also told at the
beginning of each new part of the packet to take their time, because they had unlimited
time to complete it. Unlimited time was given in each part of the session, except when
participants rated or studied the prescription drug advertisements. During the rating and
studying parts, a 15-second interval was imposed; both timed parts are described below.
Throughout the session, the experimenter instructed participants when to turn the page of
their folder or packet in order to begin the next part. The experimenter also carefully
observed participants in order to ensure that they understood the directions and procedure
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of each part. After participants completed the demographic survey, the main parts of the
experimental session began.
Participants were then instructed to open their folder to a set of 10 vignettes that
they were told to read. After participants read the vignettes, they were directed to the
ratings survey and were instructed to rate the appropriateness of the drug name for the
medical condition in a set of 10 prescription drug advertisements they were about to
view. These instructions were designed to promote incidental processing, because
participants were informed that they needed to evaluate the information. The responses
ranged from “not at all appropriate” to “extremely appropriate.” Participants were also
told that they would have 15 seconds to rate the appropriateness of the drug name for the
medical condition in each ad. During the ratings exercise, participants were instructed to
“begin,” “stop,” and “turn” (the page) until each drug name in the set of ads had been
rated. A stopwatch was used to track each time interval and a “beep,” initiated by the
experimenter, sounded at the beginning and ending of each interval.
Participants next completed the first part of the SVT, where they were instructed
to circle the word that meant the same thing, or most nearly the same thing, as the first
word. The odd/even distribution of items noted earlier was thought to provide
experimental consistency and better ensure that the two parts were comparable. The
modification of the SVT was necessary, because it was intentionally used twice in the
session as a meaningful activity, both times between the instructions (to rate or study)
and memory test (indirect or direct). Thus, it was important for both parts to be
analogous. Otherwise, if the original version had been used, participants might have
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completed items 1-20 far more quickly than items 21-40, and the latencies between the
instructions and memory test might have been significantly different.
After participants completed the first part of the SVT, they were directed to the
indirect test of memory, where they were instructed to circle the drug name from each
pair that they thought was the better drug name. The drug name pairings presented in the
test were from the process described earlier, and participants had previously rated one of
the drug names in the pairings, but not the other name. The experimenter specifically
instructed participants to circle only one of the two drug names in each of the pairings.
The incidental instructions and indirect test of memory were used collaboratively to
measure implicit memory. After both participants completed the implicit memory task,
they were told to place their packet to the side of the table and turn their attention back to
their folder. Participants were then instructed to turn to the next page in their folder,
which contained an additional set of 10 vignettes that they were told to read.
After participants read the additional vignettes, they were shown another set of 10
prescription drug advertisements. This time they were instructed to study the drug name
and associated medical condition in the drug ads for a later memory test. These
instructions were designed to promote intentional processing, because participants were
informed that they needed to remember the information. Participants were also told that
they would have 15 seconds to study the drug name and medical condition in each ad.
During the study exercise, participants were instructed to “begin,” “stop,” and “turn” (the
page) until each drug name and medical condition in the set of ads had been studied.
Again, a stopwatch was used to track each time interval and a “beep,” initiated by the
experimenter, sounded at the beginning and ending of each interval.
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Participants next completed the second part of the SVT, after which they were
directed to the direct test of memory, where they were instructed to circle the drug name
from each pair that they recognized or remembered from the advertisements. In each
case, participants had previously studied one of the drug names in the pairings, but not
the other name. Again, the experimenter instructed participants to circle only one drug
name in the pairings. The intentional instructions and direct test of memory were used
collaboratively to measure explicit memory. The procedures for measuring implicit and
explicit memory were comparable, if not identical, in that participants read vignettes,
rated or studied drug names, completed part of the SVT, and then selected between two
drug names.
After participants finished the explicit memory task, they completed the STAI
S-Anxiety scale. Participants were instructed to read each statement and then circle the
appropriate number to the right of the statement to indicate how they felt right now, at
this moment. The responses ranged from “not at all” to “very much so.” The STAI SAnxiety scale was strategically administered immediately after participants were aware
that their memory had been tested. Next, participants completed the STAI T-Anxiety
scale on which they were instructed to read each statement and then circle the appropriate
number to the right of the statement to indicate how they generally felt. The responses
ranged from “almost never” to “almost always.”
To this point, each survey, test, and scale had occupied a single page in the data
response packet. The remaining MCS and drug ad EJS consisted of two pages. As a
result, participants were instructed to complete the first page of each survey and then the
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second page, which were different instructions than they had been previously given and
had become accustomed to following.
After participants completed both scales of the STAI, they were directed to the
first page of the MCS and instructed to indicate any medical conditions they currently
had or had experienced in the last 5 years by circling Y for yes and N for no. On the
second page, they were told to circle their responses concerning their health, whether
they had any chronic health conditions, were taking any prescription medications, and
had any serious illnesses in the last 5 years. Participants were also asked to note the
number of chronic health conditions, prescription medications, and serious illnesses as
well as list them if they responded affirmatively to any of the items.
Participants were then directed to the drug ad EJS and instructed to tell how well
they thought each of the listed words described all of the ads, on average, they had just
seen by circling the number that best represented their thoughts. The experimenter
emphasized that their evaluation judgments should be for all of the drug ads that had been
rated and studied. The responses ranged from “not at all well” to “extremely well.” Both
pages of the drug ad EJS followed the same format.
After the data response packet and the main parts of the experimental session had
been completed, participants were told that there was one brief, final part of the session,
which would be conducted individually. In addition, participants were informed that one
participant would need to step out into the hallway and that the experimenter would be
with him or her in a few minutes. A chair located away from the door was provided for
the participant to sit on during the brief waiting period. The experimenter did not decide
which participant would leave and which participant would remain. This decision was
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amicably agreed upon by the participants in almost every instance, and none of them
appeared to be distressed or troubled by the change in procedure. In fact, one of the
participants would usually quickly volunteer to step out into the hallway.
When the experimental session involved only one participant, the participant was
also told that there was one brief, final part of the session, but none of the additional
information was given. Next, all folders and packets were removed from the table, and
the MMSE was administered to all participants by the experimenter. Upon completion of
the MMSE, participants were given a debriefing form, asked not share any information
about the experimental session with anyone, and thanked for their time. One older adult
participant who scored less than 24/30 on the MMSE did not have his data responses
used in the statistical analyses because a score below that threshold suggests cognitive
impairment. A diagram of the experimental sequence can be found in Appendix S. The
debriefing form can be found in Appendix T.
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CHAPTER VII
RESULTS

Analyses were performed using the SPSS statistical package (version 15.0). To
measure the effectiveness of the implicit memory manipulation, a t test was performed.
Memory measures were analyzed using a 2 x (2) mixed repeated measures analysis of
variance (ANOVA), and was performed with age group (older vs. younger) as the
between-participants factor and salience (salient vs. nonsalient) as the within-participants
factor. The repeated measures ANOVA was applied to the implicit memory measure as
well as to the explicit memory measure. One major interest was in memory for the drug
names that participants had rated or studied previously in each of the drug name pairings.
Memory was assessed by the proportion of preference in the implicit memory condition
and the proportion of recognition in the explicit memory condition.
In addition to the primary statistical analyses, secondary analyses were performed,
such as correlational analyses that examined the relationships between memory and
anxiety (state and trait) and the influence of age, salience, and type of memory measure
on the memory-anxiety relationship. A 2 (age group) x (2) (salience) analysis of
covariance (ANCOVA) with state anxiety as the covariate was also performed. Taken
together, the statistical analyses adequately examined the data set and addressed the
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research questions and hypotheses. The means and standard deviations for measures in all
conditions can be found in Table 1.

Table 1
Means and Standard Deviations for Memory and Anxiety Measures
Older Adults

Younger Adults

Measure
Implicit Memory Salient
Implicit Memory Nonsalient
Explicit Memory Salient
Explicit Memory Nonsalient

M
2.97
3.01
4.26
4.25

SD
1.07
1.25
0.80
0.97

M
2.83
2.99
4.55
4.46

SD
1.12
1.20
0.81
0.81

State Anxiety
Trait Anxiety

29.63
32.59

9.02
7.52

34.45
37.77

10.08
7.17

Implicit Memory
As a check on the success of the implicit memory manipulation, the correct
response total for overall implicit memory was tested with a t test to determine whether
performance was greater than chance. The implicit memory performance correct response
total (M = 5.90) was significantly different from chance performance (M = 5.00), t(158) =
6.89, p <. 001. Therefore, implicit memory was effectively manipulated in the study.
A repeated measures ANOVA for a mixed experimental design with one
between-participants factor (age group) and one within-participants factor (salience) was
performed to examine the effects of age group and salience on implicit memory. One
purpose of the analysis was to determine the main effect of the presentation of salient
information on implicit memory. The analysis indicated no significant difference in
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implicit memory for the salient items versus the nonsalient items, F(1, 157) = 0.60,
p = .44, partial-Ș² = .004.
The main effect for age group on implicit memory also was not significant, F(1,
157) = 0.45, p = .51, partial-Ș² = .003. The age x salience interaction for implicit memory
also was not significant, F(1, 157) = 0.23, p = .63, partial-Ș² = .001. See Table 1 for
means and standard deviations of the various measures.
The results of the analyses were consistent with the first and second hypotheses.
The analysis indicated no significant difference in salience for implicit memory, no
significant difference between age groups for implicit memory, and no significant
interaction effect between salience and age groups for implicit memory. See Table 2 for
the complete source table for the ANOVA.

Table 2
Repeated Measures Analysis of Variance for Implicit Memory
Source
Between participants
Age group
Error 1
Within participants
Salience
Salience x Age group
Error 2
p < .05

df

SS

MS

F

p

partial-Ș²

1
157

0.61
213.59

0.61
1.36

0.45

.51

.003

1
1
157

0.80
0.31
209.89

0.80
0.31
1.34

0.60
0.23

.44
.63

.004
.001

Explicit Memory
A parallel repeated measures ANOVA for a mixed experimental design was used
to examine the effects of age and salience on explicit memory. Again, the design
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employed one between-participants factor (age group) and one within-participants factor
(salience). One purpose of the analysis was to determine the main effect of the
presentation of salient information on explicit memory. The analysis indicated no
significant difference in explicit memory for the salient items versus the nonsalient items,
F(1, 153) = 0.34, p = .56, partial-Ș² = .002.
The main effect for age group on explicit memory was significant, F(1, 153) =
4.19, p < .04, partial-Ș² = .027. The older adults recognized an average of 4.28 (SE = .08)
drug names, and the younger adults recognized an average of 4.51 (SE = .08) drug names.
The age x salience interaction for explicit memory was not significant, F(1, 153) = 0.34,
p = .56, partial-Ș² = .002. See Table 1 for means and standard deviations of measures.
The results of the analyses were consistent with the first hypothesis, but
inconsistent with the second hypothesis. The analysis indicated a significant difference
between age groups for explicit memory. However, the analysis also indicated no
significant difference in salience for explicit memory and no significant interaction effect
between salience and age groups for explicit memory. See Table 3 for the complete
source table for the ANOVA.
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Table 3
Repeated Measures Analysis of Variance for Explicit Memory
Source
Between participants
Age group
Error 1
Within participants
Salience
Salience x Age group
Error 2
*p < .05

df

SS

MS

F

p

1
153

3.96
144.73

3.96
0.95

4.19

.04*

.027

1
1
153

0.15
0.15
67.19

0.15
0.15
0.44

0.34
0.34

.56
.56

.002
.002

partial-Ș²

Anxiety and Memory Performance
Correlations were examined to assess the relationships between anxiety and
memory performance. In particular, correlations were computed between the type of
anxiety (state and trait) and the type of memory performance (implicit and explicit), with
participant subgroups divided by type of salience and age groups. In addition, scatterplots
were examined for all of the correlations, and no outliers, influence points, or nonlinear
trends were noted. Nonetheless, no significant correlations were found between anxiety
and memory performance.
Further, to determine if state anxiety played a role in the analysis of age group and
salience on the memory measures (from the third hypothesis), the 2 x (2) analyses were
repeated with state anxiety as the covariate. The ANCOVAs showed that the state anxiety
covariate was not significant, either for the implicit memory measure, F(1, 150) = 2.16, p
= .14, partial-Ș² = .014, or for the explicit memory measure, F(1, 147) = 3.18, p = .08,
partial-Ș² = .021. Tables 4 and 5 contain the complete source tables for each of the
ANCOVAs.
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Table 4
Repeated Measures Analysis of Covariance for Implicit Memory
Source
Between participants
Age group
State anxiety
Error 1
Within participants
Salience
Salience x Age group
Salience x State anxiety
Error 2
p < .05

df

SS

MS

F

p

partial-Ș²

1
1
150

1.84
2.93
203.46

1.84
2.93
1.36

1.36
2.16

.25
.14

.009
.014

1
1
1
150

1.81
1.00
1.32
201.90

1.81
1.00
1.32
1.35

1.34
0.74
0.98

.25
.39
.32

.009
.005
.006

p

partial-Ș²

Table 5
Repeated Measures Analysis of Covariance for Explicit Memory
Source
Between participants
Age group
State anxiety
Error 1
Within participants
Salience
Salience x Age group
Salience x State anxiety
Error 2
*p < .05

df

SS

MS

F

1
1
147

4.81
2.97
137.36

4.81
2.97
0.93

5.15
3.18

.03*
.08

.034
.021

1
1
1
147

0.00
0.11
0.03
64.04

0.00
0.11
0.03
0.44

0.00
0.26
0.08

.96
.61
.78

.000
.002
.001

The collected results of the correlational analyses were partially consistent with
the third hypothesis. That is, the analyses indicated no significant relationships between
anxiety and memory performance. As expected, no significant correlation between state
anxiety and implicit memory was found; however, contrary to expectation, no significant
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correlation between state anxiety and explicit memory was found. See Tables 6 and 7 for
correlations between anxiety and memory measures in older and younger adults,
respectively.

Table 6
Correlations for Memory and Anxiety Measures in Older Adults
State Anxiety
Implicit Memory Salient
Implicit Memory Nonsalient
Explicit Memory Salient
Explicit Memory Nonsalient
State Anxiety
**p < 0.01

.17
-.07
-.10
-.16

Trait Anxiety
.11
-.12
-.10
-.13
.47**

Table 7
Correlations for Memory and Anxiety Measures in Younger Adults
State Anxiety
Implicit Memory Salient
Implicit Memory Nonsalient
Explicit Memory Salient
Explicit Memory Nonsalient
State Anxiety
**p < 0.01

.13
.11
-.10
-.10

Trait Anxiety
.06
-.02
-.05
-.07
.44**

Summary Results
For implicit memory, no significant difference in salience or between age groups
was found, and no significant interaction effect between salience and age groups was
established. For explicit memory, a significant difference between age groups was found,
but no significant difference in salience was found and no significant interaction effect
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between salience and age groups was established. No significant correlations were found
for anxiety and memory performance.
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CHAPTER VIII
DISCUSSION

Prescription drug advertisements have become commonplace in magazines and on
television, because pharmaceutical company expenditures for drug ads continue to
increase. Accordingly, the public has become rather familiar with drug ads, because the
ads make it appear that medications are available for almost any condition. Many of the
drug ads are aimed at older adults, because they are viewed as more likely to use
medications than younger adults. However, the effectiveness of drug ads on influencing
older adults’ requests for prescriptions is uncertain. Although previous research has
indicated that older adults do not explicitly remember drug ads as well as younger adults
(Abernathy & Adams-Price, 2006), how well older adults implicitly remember drug ads
is not known. In addition, research has found age differences favoring the young are
typically found on explicit memory tasks, but not on implicit memory tasks (Light &
Singh, 1987, Light et al., 1986). One implication of research showing fewer age
differences in implicit memory is that older adults may be influenced implicitly by drug
ads even though they cannot explicitly remember seeing them.
Implicit memory involves unconscious awareness and unintentional processing,
and it is evidenced through improvement in task performance as a result of previous
exposure to a stimulus even though a person has no conscious memory of the previous
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exposure. Therefore, previous experiences and events can have an influence on present
responses even when a person cannot consciously remember them. Explicit memory
involves conscious awareness and intentional processing. Implicit memory is measured
with incidental instructions and indirect tests, and explicit memory is measured with
intentional instructions and direct tests. Many researchers have examined implicit and
explicit memory and have found differences between them in various groups including
brain-damaged adults (e.g., Graf & Schacter, 1985), cognitively intact adults (e.g.,
Tulving et al., 1982), and the elderly (e.g., Light et al., 1986). In general, the studies have
found group differences in explicit memory, but not in implicit memory.
The primary purpose of the current study was to compare older and younger
adults’ implicit and explicit memory for magazine-style prescription drug advertisements.
A secondary purpose of the study was to determine whether age differences in implicit
and explicit memory were affected by salient information and level of anxiety. Another
overall objective of the study was to demonstrate that an indirect test of implicit memory
adds value to the process of estimating advertising effectiveness.
The study was theoretically important because it contributed to cognitive aging
research and examined memory within an everyday context. Some forms of cognitive
performance, such as explicit memory, decline in older adults. Nonetheless, some forms
of cognitive performance, such as implicit memory, appear to be relatively spared from
cognitive age-related deficits. The results showed no age difference for implicit memory
for drug advertisements, although an age difference was found for explicit memory for
drug ads. Therefore, the findings were consistent with other memory research (e.g., Graf
& Schacter, 1985; Light et al., 1986; Tulving et al., 1982), except that everyday stimuli
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were used in this study. In addition, this study also tested the hypotheses that an observed
age difference in explicit memory might be related to the salience of the stimuli or to
anxiety.
The study was practically important because pharmaceutical companies spend
vast amounts of money on prescription drug advertisements that may or may not be
effective with their target population: older adults. Presenting drug ads directly to
consumers has also affected the dynamics of the health care industry. The drug ads used
in this study appeared to be effective based on implicit and explicit memory for them,
even though older adults performed slightly more poorly on explicit memory.

Study Findings
The primary objective in the current study was to examine implicit and explicit
memory for prescription drug advertisements in older and younger adults. Of particular
interest was whether there are differences between older and younger adults in implicit
and explicit memory for drug ads and the significance or size of any observed
differences. It was hypothesized that a significant age difference would be found for
explicit memory between older and younger adults, with older adults performing more
poorly, but that no such age difference would be found for implicit memory. As expected,
the results demonstrated a significant age difference in explicit memory between older
and younger adults, and the study also found no significant difference in implicit memory
between the groups. Therefore, the findings supported the first hypothesis.
The implicit and explicit memory results are not surprising. In fact, the results
were comparable to most previous research that has examined implicit and explicit
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memory in older and younger adults: no age difference for implicit memory, but an age
difference for explicit memory (Brooks et al., 2001; Light & Singh, 1987, Light et al.,
1986; Mitchell, 1989; Mitchell & Bruss, 2003; O’Hanlon et al., 2001). Accordingly, this
study successfully replicated a series of previous studies. The component of this study
that may be most important is that the results expanded everyday memory research to
another context using an implicit memory measure of mere exposure. In other words, this
study addressed the effectiveness of prescription drug advertising with an indirect test,
and the drug ads were found to be effective. Thus, the results were specific to the realworld setting of drug advertising and the older adult consumers that most drug ads are
attempting to influence.
Advertising effectiveness is demonstrated by positive brand feeling, which is
sometimes called brand equity. Brand equity influences purchase decision making and
buying behavior (Cramphorn, 2006; Plassmann et al., 2007). Repeated exposure to
brands through advertisements can increase brand equity (Braun-LaTour & LaTour,
2004). Repeated exposure can also increase brand familiarity and preference for those
brands (Coates et al., 2004; 2006).
Measuring memory for prescription drug advertising is consistent with the recent
movement in memory research called everyday memory, which is studying memory in
everyday contexts or settings. Neisser (1978) recommended that more real-world
memory research was needed in order to further the application of its findings. This study
used stimuli from the real-world context of drug advertising and measured implicit and
explicit memory in a controlled environment. Therefore, this study involved a realistic
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setting and maintained experimental control in addressing its objectives, which gives its
results an acceptable degree of ecological validity and generalizability.
A secondary objective was to examine the effect of salient information on implicit
and explicit memory for drug advertisements in older and younger adults. Of interest was
whether salience influenced differences in implicit and explicit memory in the different
age groups based on research indicating the positive effects of salience (e.g., Hulicka &
Weiss, 1965; Perri & Nelson, 1987). Salient information was expected to reduce the age
difference found in explicit memory between older and younger adults, but to have no
impact on implicit memory because no age difference is typically found in performance.
The results indicated that salient information had no effect on either explicit or implicit
memory. Therefore, the findings did not support the second hypothesis, because salience
had no effect on explicit memory.
A few explanations might account for the lack of significance for the salience
effect. One explanation centers on the experimental procedure. For example, the salience
manipulation may not have worked because aspects of the procedure were ineffective
because of the way it was performed. Initially, the medical conditions were presented to
participants through the reading of vignettes. Next, the medical conditions were paired
with drug names in the drug advertisements. Then, participants were instructed either to
rate or study the conditions and names in the drug ads depending upon the experimental
condition. Finally, memory was either indirectly or directly measured for the drug names
in the drug ads.
Too many vignettes and drug advertisements may have been presented, and this
may have diminished the salience of the stimuli. In addition, the stimuli were only
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semantically associated or related at the learning episode and at testing and thus, were not
the same. That is, information for the medical conditions was presented in the vignettes,
but memory was only measured for the drug names. As a result, there may have been no
exact connection made between the conditions and names, and the vignettes may have
been too weak and ineffective to work as a proper form of salience or environmental
support for the drug ads.
A second explanation focuses on the emotional words used in the vignettes. The
purpose of the words was to elicit or evoke emotion from the readers. Although the
carefully selected emotional words were rated as being both generally unpleasant and
excitable, they were neither extremely unpleasant nor excitable. Because the words were
mostly, but not entirely, emotional, they may not have induced sufficient emotion from
participants. In other words, the vignettes might have appeared more casual and matterof-fact, rather than moving and stirring. In addition, the reading of 10 consecutive
vignettes in a brief period of time may have also resulted in their blending together and
eliminating the possibility of a salience effect. Blending means that the vignettes may
have appeared more alike than different to participants. A habituation effect is
particularly likely because the vignettes followed a specific template and thus, were not
very distinctive.
A third explanation concerns the amount of time participants were exposed to the
drug advertisements. Although participants rated and studied drug ads, they were only
exposed to them for 15 seconds each. They were instructed to concentrate on the drug
name as it related to the medical condition during that time frame, but the length of time
may not have been sufficient enough to establish a semantic relationship between the
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name and condition. In addition, this duration was relatively brief and the exposure to 10
consecutive drug ads might also have had a habituation effect, comparable to the reading
of the vignettes, which reduced the likelihood of a salience effect occurring.
An additional objective was to examine the effect of anxiety on implicit and
explicit memory for drug advertisements in older and younger adults. Of interest was
whether anxiety influenced differences in implicit and explicit memory in the different
age groups based on research indicating the negative effects of anxiety (e.g., Andreoletti
et al., 2006; Deptula et al., 1993; Hogan, 2003; Wetherell et al., 2002). State anxiety was
expected to be negatively correlated with explicit memory in older but not younger
adults, but it was not expected to be correlated with implicit memory because
performance is usually equally good in both groups. The results indicated that state
anxiety was not correlated with either explicit or implicit memory performance.
Therefore, the findings did not support the third hypothesis, because state anxiety had no
relationship with explicit memory.
A few explanations might also account for the lack of relationship between
anxiety and memory. One explanation centers on the length of the direct test used to
measure explicit memory. The direct test of memory included 10 drug name pairings that
required a simple decision-making process. Because both the older and younger adults
usually completed it quickly, perhaps the direct test was too abbreviated to show a
relationship between anxiety and memory. The ability to complete the direct test
promptly suggests that it was not challenging enough to participants to produce much
anxiety, even in the older adults.

103

A second explanation focuses on the type of direct test used to measure explicit
memory. The test was a recognition task, and performance is usually better on
recognition tasks than on recall tasks in both older and younger adults. Recognition tasks
involve more automatic processing and require far less deliberate processing than recall
tasks, making older adults’ performance on them similar to younger adults’ performance
(Craik, 1994; Craik & McDowd, 1987; Hasher & Zacks, 1979). Again, the direct test
may not have been challenging enough to participants because it was a recognition task.
If the direct test had been longer and had taken more time or had been a recall task, more
state anxiety might have been produced in participants, particularly the older adults, with
a subsequent impact on explicit memory. For this study, the direct test of memory was
developed purposefully to be comparable to the indirect test of memory. Because the
indirect test asked participants to make simple preference choices between two drug
names, the direct test followed the same format. The resulting recognition task, although
completed more successfully by younger adults than older adults, was relatively easy for
both groups.
Taken together, the length of the task and the type of task are important to
consider when trying to explain the lack of relationship between anxiety and explicit
memory. Both state and trait anxiety were strategically measured, in that order,
immediately after the explicit memory task.
The reason that anxiety was measured at that point in the study was because it
was believed to be the time when participants, particularly the older adults, would
experience the most anxiety. The idea that older adults would be experiencing anxiety
after the measurement of explicit memory came from metamemory research showing that
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older adults report low confidence in their memory ability and high fear of memory
problems (Dixon & Hultsch, 1983; Hertzog et al., 1990; Lachman, 1991). In addition,
research on stereotype threat and memory in older adults suggests that their memory is
reduced when they are aware of the stereotype that older adults are poor at remembering
(Chasteen et al., 2005; Hess et al., 2003). Thus, people’s awareness that their memory is
being tested in explicit memory tasks may cause anxiety, and the presence of that anxiety
brings about cognitive deficits in older adults. Therefore, task-related anxiety is another
explanation for cognitive deficits in older adults, and research has shown that elevated
anxiety is associated with poorer cognitive performance in older adults, especially in
memory (Andreoletti et al., 2006; Deptula et al., 1993; Hogan, 2003; Osborne, 2007;
Wetherell et al., 2002).
Despite the placement of the anxiety measure, little anxiety was found. Perhaps
another measure of anxiety would have detected more anxiety. It is also possible that the
instructions used for the direct memory test would have produced more stereotype threat
if they had mentioned the age-memory stereotype. In addition, it is possible that more
anxiety would have been detected if anxiety had been measured immediately before the
direct memory test, as opposed to right after the test. Because the older adults performed
relatively well on the direct memory test, their level of anxiety after the test may have
been lower than it was before the test.
A third explanation for the lack of relationship between anxiety and memory
concerns the level of education in the older adult group. Over half of the older adults
were college graduates with some post-graduation education. Therefore, the older adults
were collectively a highly educated group, potentially making the direct test of memory
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less challenging because educated older adults tend to age, particularly cognitively, more
successfully than uneducated older adults (Baltes, 1997; Hess, 2005). In fact, the
education variable alone makes the results of this study less generalizable to the
population at large. Perhaps a measure of metamemory should have been administered to
participants in order to attain a measurement of memory self-efficacy. If highly educated
older adults are more confident in their cognitive abilities, especially on a specific task,
they may not experience as much anxiety as most older adults when their memory is
tested.
A final explanation has to do with the memory performance. Both the older and
younger adults performed well in both implicit and explicit memory. In fact, the explicit
memory average scores were high for both groups, especially the younger adults. In
addition, there was no significant difference found in either implicit or explicit memory
between the salient items versus the nonsalient items. Therefore, the observed ceiling
effect of the explicit memory average scores might have contributed to the lack of
relationship between anxiety and memory. Participants may also have felt comfortable
and relaxed at the testing site and thus, experienced little anxiety. This might particularly
have been true for the older adults, who were tested at a local church.

Study Strengths
First, the stimuli were extensively pretested and pilot-tested in order to provide
greater experimental consistency and control. This should also have minimized the
influence of any potential extraneous variables. In addition, a set of decision rules was
carefully established in developing and creating the stimuli (e.g., vignettes, drug ads).
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Strategic counterbalancing was performed in the experimental packets as well as in the
data response packet. Additionally, the experimental procedure was highly structured and
precise. Therefore, the medical condition vignettes and prescription drug advertisements
were generated with consistency and control, and the potential for any ordering effects
that might have influenced the results were minimized.
Second, the number of participants in each group was more than adequate to
detect or establish a medium effect size at the .05 significance level, with sufficient
statistical power at .80, in order to identify any significant differences in the various
analyses (Cohen, 1992). The MMSE was administered at the end of the experiment, and
practically all participants performed well on it. Thus, their scores indicated that both
groups were similar in cognitive performance even after a lengthy testing session and a
battery of tests.
Third, the study employed incidental instructions and an indirect test to measure
implicit memory as well as intentional instructions and a direct test to measure explicit
memory. These instructions/test groupings represent the truest methods for measuring
implicit and explicit memory. This methodological component is a strength of the study,
especially when compared to numerous previous studies that claimed to have measured
both types of memory but used a variety of instructions/test groupings, which makes it
difficult to determine the type of memory being measured. In summary, both implicit and
explicit memory were measured in the current study using the most valid procedures
available.
A general strength of the study is that it demonstrated that value of employing the
implicit memory paradigm in helping determine advertising effectiveness. The implicit
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memory measure used in the study based on the mere exposure effect would be useful to
advertisers in order to better detect the subtle effects of advertising (e.g., Coates et al.,
2006; Duke & Carlson, 1993; Yoo, 2008).

Study Limitations
First, fictitious stimuli were employed, such as prescription drug names that were
used in both rounds of the pilot testing as well as in the study. Some of the drug names
were similar to common names of actual drugs that have been advertised, are currently
being advertised, or drugs that participants may take (e.g., Tylomex vs. Tylenol, Zolatol
vs. Zoloft). The similarity between the fictitious and actual drug names may have resulted
from either the appearance (spelling) or pronunciation (sounds) of the names. Any
perceived similarity by participants in any phase of the pilot testing or the study could
have caused some drug names to have an unintentional advantage over other names that
might not have shown up in pretesting with the young.
A follow-up study using fictitious drug names could avoid this potential limitation
by pilot testing in order to validate that the drug names seem completely novel and
unfamiliar to participants. Because a few of the older adults commented without being
asked that they had not previously seen any of the drug names, it was assumed, perhaps
erroneously, that participants were not familiar with the drug name stimuli.
In the pilot-testing process, participants rated drug names and compared drug
name pairs without reference to a medical condition, and a few participants asked about
the condition for which the names were being evaluated. A follow-up study could
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incorporate decision making about drug names that are related to specific medical
conditions.
Second, some uncertainty about the authenticity of the prescription drug
advertisements may have occurred. The drug ads used in the study were developed to
resemble real drug ads that are found in popular magazines. The research team attempted
to create drug ads that appeared authentic within the experimental confines of the study.
Drug ads that might have appeared unauthentic could have slightly affected participants’
responses. To compensate for this potentially problematic perception, participants were
informed in the instructions before both sets of drug ads that the ads were “works in
progress” and “potential ads.” In addition to the instructions, evaluation judgments of all
of the drug ads together were collected in order to estimate participants’ perceptions of
the ads. The older adults’ average score per item for the evaluation judgments was 2.99
(SD = 0.70), and the younger adults’ average score per item was 3.09 (SD = 0.57). The
mean scores indicate that participants thought the drug ads were “fairly well” described
as being believable, informative, worth remembering, etc. based on a 5-point Likert-style
scale. The difference between the average scores of the evaluation judgments of the older
and younger adults was not significant.
Third, older adults probably know more about medical conditions and
prescription drugs than younger adults. As expected, older adults reported having more
chronic health conditions and taking more prescription medications. However, it is
uncertain how having greater knowledge of health information might have affected the
results, and it would be difficult to regulate older adults’ knowledge of health
information. Because the drug ad stimuli were fictitious, this potential limitation was at
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least partially addressed in the study. Nonetheless, more knowledge in the health area
might have affected some perceptions and responses of the older adults.

Conclusions and Recommendations
Cognitive aging research has repeatedly demonstrated that older adults, compared
to younger adults, display cognitive deficits, particularly memory deficits, across
numerous tasks and situations (e.g., Craik, 1994; Craik & McDowd, 1987; Hess, 2005;
Salthouse, 2004). This study successfully replicated previous research that found
differences or dissociations between implicit and explicit memory in older and younger
adults (Brooks et al., 2001; Mitchell, 1989; Mitchell & Bruss, 2003; O’Hanlon et al.,
2001). As expected, no significant age difference was found in implicit memory, whereas
an age difference was found in explicit memory. However, this study did not find that
salient information or anxiety influenced either type of memory in either group.
The prescription drug advertising context in which memory was measured may be
the most important component of this study, because it is consistent with the current
movement in memory research called everyday memory. The everyday memory
movement examines memory in customary contexts or settings. In addition, implicit and
explicit memory research was extended to another real-world context, which gives it
further practical application. In other words, although the results may not have
established any novel memory findings, the research was conducted in a contemporary,
everyday memory situation within a controlled environment. Additionally, this study
addressed the effectiveness of drug advertising in older adult consumers, who constitute
the target audience for most drug ads. Advertising effectiveness was also measured by a
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less frequently used implicit memory measure of mere exposure. Therefore, this study
involved a realistic setting and maintained experimental control in measuring memory,
which provided an acceptable degree of ecological validity and generalizability to the
results.
Future studies may want to consider the various explanations for why the salience
and anxiety manipulations had no effect on memory. The modifications in the stimuli and
procedure in a follow-up study needed to address the possible problems with this study
are readily achievable. The limitations of this study may also add valuable information
for developing a follow-up study. Plus, a careful consideration of the limitations in the
stimuli development (e.g., drug names, drug ads) may enable another similar study to
control better for the influence of additional extraneous variables.
In review, there are a number of explanations for why salience had no effect on
memory. First, the presentation of the salient information did not seem to have allowed
for a direct connection to have been made between the conditions and names. The
presentation method seemed to have resulted in a weaker salience manipulation, whereas
the use of a different presentation might have resulted in a stronger manipulation.
Second, the inclusion of extremely emotional words in the vignettes, rather than the
generally emotional words that were used might have made the salience manipulation
more effective. Perhaps the salient vignettes should have included emotional words in
order to better attract attention to the medical conditions, and the nonsalient vignettes
should have included nonemotional words. Third, more time of exposure to the drug ads
might have resulted in a salience effect on memory.
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There are also a number of explanations for why anxiety had no effect on
memory. First, a relatively short, direct test of memory was used; perhaps a lengthier, test
of explicit memory should have been used. Second, a relatively easy recognition task was
used, whereas a more difficult recall task to measure explicit memory would have been
preferable. Interestingly, an age difference was found in this study for explicit memory
using a recognition task. Most research has shown recognition memory performance to
be comparable among older and younger adults: no age difference (Craik, 1994; Craik &
McDowd, 1987).
A lengthier and more difficult test of recall might have been more challenging and
created more anxiety in participants, particularly the older adults. Metamemory and
stereotype threat might have had more of an influence on memory if the direct test of
memory had been modified to be lengthier and more difficult. Third, the older adult
group that participated was not a representative sample because of their high level of
education. A sample of older adults more representative of the general population would
probably be found in a city or town that is not a college community. In addition, another
measure of anxiety might have identified the presence of more anxiety. Also, adding a
measure of metamemory might have provided additional information concerning older
adults’ thoughts about their memory.
The results of the STAI might be flawed because several of the items on the
anxiety scales are worded oppositely (positive and negative) in conflicting directions
(e.g., I feel pleasant, I feel nervous and restless). Some participants, especially the older
adults, may have become confused in responding because of the wording. After
participants became familiar with the direction of the response scale on a couple of items,
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the wording of the statements would change in the other direction (from positive to
negative or vice versa) and a response consistent with preceding items would then be at
the opposite end of the response scale. In support of this possibility, a recent study
compared the performance of various self-report measures of anxiety in older adults, and
the STAI T-Anxiety scale was eliminated from consideration because of the high number
of errors older adults made on it (Dennis, Boddington, & Funnell, 2007). In addition,
Dennis et al. concluded that none of the measures adequately assessed anxiety in older
adults. The experimenters observed the responses of the older adults to avoid this
potential problem, but it might have occurred at times. Perhaps higher anxiety ratings
would have been found if a more sophisticated measure of anxiety had been available.
One significant methodological concern is the length of time between exposure to
the drug ads and testing memory for the drug names. After participants either rated or
studied the drug ads, they completed an equivalent part of the SVT. On average, this task
took two minutes to complete, and then participants’ memory was tested. Therefore, the
length of time between exposure to the drug ads and testing memory for the drug names
was brief. The short time between exposure and testing probably contributed to the high
explicit memory average scores obtained (ceiling effect). Future studies should develop a
procedure to ensure that more time lapses between the learning episode and testing.
Some theoretical issues and questions of interest for future research are noted
below. For example, an age difference favoring the young was found in recognition
memory performance. Because an age difference is usually not found in recognition
tasks, one possible explanation is that the prescription drug advertising context played a
role in the observed age difference even though older adults probably have more health
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knowledge. An everyday context should provide environmental support for memory
making performance better, especially in older adults. Recognition memory performance
might be different in older and younger adults depending on the real-world stimuli that
are used. Drug advertisers might also benefit from studies that address the informationprocessing abilities of older adults relative to the arrangement of the ad information, the
amount of the ad information, or the information from the ad that is better remembered.
Thus, informational aspects of the drug ad such studies might determine: which
arrangement of information is most effective; the amount of information that is too much
or little to be effective; and which information is easier to remember.
One practical issue of interest for future research concerns ethics. For example,
some might consider it unethical for psychologists to provide information to advertisers
that would help them make their ads more effective.
There are potential advantages for research on aging and memory for prescription
drug advertisements. For example, research may show that drug ads may encourage
people to get treatment for undertreated medical conditions and increase health-related
knowledge (Schommer et al., 1998). Research using indirect tests of memory can also
demonstrate that drug ads can be effective at encouraging people to accept needed
treatment even when those people do not specifically remember the ads for those drugs.
In addition, making advertisers aware of the limits in the information-processing abilities
of older adults would enable them to increase the effectiveness of the drug ads.
Therefore, advertisers may be able to develop drug ads that are more easily remembered
and understood by older adults.
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However, research on aging and memory for prescription drug advertisements
could also bring about some potential disadvantages. For example, Findlay (2001),
McGinley (1999), and Schommer et al. (1998) suggested that drug ads promote
expensive brand name drugs, rather than generic alternative drugs, and may increase the
cost of health care. In addition, the number of older adult patients asking their physicians
for certain drugs may increase and potentially complicate their relationship with their
physicians or compromise their treatment. Rising health care costs and drug requests are
possible, because drug ads are becoming more effective because of increased frequency
and the growing amounts of money spent on them. Although advertisers want ads to be
persuasive, ads for everyday, commonly used products are different from ads promoting
better health. Drug ads must be carefully designed to inform consumers with precise
information, rather than to manipulate them with promising information. Again, some
might question whether it is ethical for psychologists to help advertisers make their ads
more persuasive.
Examinations of memory for prescription drug advertisements that treat medical
conditions participants actually have might provide some additional helpful information
for this area of research. In particular, older adults may be more affected by drug ads that
are for conditions they commonly experience. Future studies might want to examine if
memory is better for drug ads that describe personally experienced conditions, if people
pay more attention to relevant ads, and if so, the particular information they attend to in
them.
An overall objective of this study was to demonstrate and establish that a
complete assessment of advertising effectiveness should include an indirect test to assess
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implicit memory, in addition to a direct test to assess explicit memory. The former
measurement frequently has been overlooked, and the latter measurement repeatedly has
been overused when estimating advertising effectiveness. Advertising effectiveness has
been measured traditionally by direct tests of memory (Holden & Vanhuele, 1999;
Shapiro & Krishnan, 2001; Perfect & Askew, 1994). However, the use of direct tests of
memory solely to measure ad effectiveness may be a mistake. In order to address the
mistake, researchers should use indirect tests of memory within the implicit memory
paradigm. Both measurements are needed for a full assessment.
The observation that the implicit memory manipulation was successful
accomplished this objective. The indirect test of implicit memory revealed that exposure
to the drug ads did influence memory; that is, the ads were persuasive. Therefore,
unconscious processing is influenced by previous activities even when a person cannot
remember the activities. Within an everyday context, further examinations of cognition in
general, and memory in particular, without conscious awareness and deliberate
processing might illustrate just how influential and powerful unconscious processes are in
shaping behavior.
Similar to the results of this study, other research has demonstrated that an
assessment of implicit memory is a viable alternative for measuring advertising
effectiveness (Holden & Vanhuele, 1999; Krishnan & Shapiro, 1996; Shapiro &
Krishnan, 2001; Shapiro et al., 1997). An indirect test indicates whether the
advertisement made a favorable impression on the consumer, which may in turn
influence buying behavior. A consideration of affective differences, as measured by
implicit tests of memory, is an innovative way to further examine and assess ad
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effectiveness. As a result, indirect tests should be more widely promoted to advertisers
and used by them to measure ad effectiveness (Duke & Carlson, 1993; Shapiro et al.,
1999). Advertisers should begin using indirect tests of implicit memory as gauges for
persuasion and affect in order to determine the influence of unconscious processes on the
effectiveness of ads.
Future research should examine implicit memory for internet advertising. The
prevalence of internet advertising is increasing. Similar to other advertising findings,
directly measuring memory for internet ad information has been found to be poor;
however, indirectly measuring memory has been found to be good. Also similar to other
research, brand choice is favorably influenced after a single exposure to internet
advertising (Yoo, 2008).
Using advertising effectiveness measures based solely on conscious decision
making can lead to the conclusion that advertisements are not very effective. This may be
especially true for internet ads, which may be less likely to be consciously recalled than
magazine ads. However, implicit memory measures can be employed to complement
explicit memory measures to demonstrate ad effectiveness. Explicit measures have
limitations that implicit measures do not have because explicit measures require
conscious awareness, whereas implicit measures do not (Yoo, 2008).
The mere exposure effect (Zajonc, 1980) is an excellent example of implicit
memory that is relevant to the goal of persuasion in advertising. Because advertisers aim
to persuade consumers to like their products and eventually purchase them, it makes
sense to measure advertising effectiveness using indirect tests of implicit memory to
assess affective differences. Therefore, the use of the implicit memory paradigm and its
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associated affective measures provides another practical means to assess memory for
advertisements, which contributes to determining their overall effectiveness (Butler &
Berry, 2001; Duke & Carlson, 1993; Finlay et al., 2005; Goode, 2007; Krishnan &
Shapiro, 1996; Shapiro et al., 1999). Thus, a complete assessment of ad effectiveness
requires tests of familiarity and preference in order to assess implicit, in addition to
explicit, memory for ads (Krishnan & Shapiro).
Given that older adults have poorer explicit memory than younger adults, but not
poorer implicit memory, it is particularly important for advertisers to use implicit
memory measures when assessing advertisements aimed at older adult consumers. Future
research should also examine the effects of repeated exposure to ads on older adults’
perceptions of drug ads, and older adults’ memory for the source of drug ads. Such
studies would allow future researchers and advertisers to compare the cumulative effects
of drug ads over time on decisions to take particular medications, especially brand name
drugs versus generic alternative drugs. Such decisions can affect the cost and quality of
health care for older adults.
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Consent Statement and Description of the Experiment
Perceptions of Potential Prescription Drug Advertisements
Mississippi State, Mississippi 39762
Ty Abernathy, Mississippi State University
Dr. Carolyn Adams-Price, Mississippi State University

(662) 325-0595
(662) 325-7658

Prescription drug advertising on television and in magazines has affected the health
behaviors of Americans in both positive and negative ways. The purpose of this research
is to examine perceptions of potential prescription drug advertisements, and to assess the
potential impact of the ads on viewers.
You will be asked to examine some potential drug advertisements and to rate them on
several characteristics. In addition, you will be asked to complete some questionnaires
about your health and well-being. You will also be asked to complete some measures that
assess your mental skills. Your participation in this experiment should take
approximately one hour.
Your participation in this experiment is completely voluntary. You may withdraw at any
time or refuse to answer any specific question. There are no expected risks or discomforts
associated with your participation. Your input will enable the researchers to better
understand how potential prescription drug advertisements are perceived and the roles
certain mental skills play in that perception. Mississippi State University students will
receive 1 research credit for their participation in this experiment.
Personal information, such as your name, will be stored separately from your responses
to questionnaires and other data. Your responses in this experiment will be kept
confidential and stored in a locked cabinet. No one other than the researchers will have
access to your responses. *Also, please note that these records will be held by a state
entity and therefore are subject to disclosure if required by law.
Please contact the researchers noted above with any concerns or questions you may have
about this experiment or your participation in it. The Institutional Review Board approval
number for this experiment is 07-254. For additional information regarding your rights as
a research participant, please feel free contact the Mississippi State University Regulatory
Compliance Office at (662) 325-5220.
Please understand that your participation is voluntary, your refusal to participate will
involve no penalty or loss of benefits to which you are otherwise entitled, and you
may discontinue your participation at any time without penalty or loss of benefits.
Thank you for your participation in this experiment.
You will be given a copy of this form for your records.
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______________________________
Participant Signature

_______________
Date

______________________________
Investigator Signature

_______________
Date

______________________________
Investigator Signature

_______________
Date
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1. How old are you?
_____ years
2. Please circle your gender:
male

female

3. Please circle your race/ethnicity:
Caucasian/white
Hispanic
Asian

African-American/black
American Indian
other _______________

4. Please circle your education level:
college graduate with some post-graduation education
college graduate
some college
high school graduate (or general equivalency diploma)
did not complete high school (if not, please indicate the
highest grade completed _____)
5. Please circle your marital status:
married
divorced/separated

single
widowed

6. Please circle your current occupational status:
student
retired
disabled
homemaker

working full-time
working part-time
unemployed (looking for work)
unemployed (not looking for work)

7. How long have you lived at your current residence?
_____ years
8. Please circle the size of the largest city/town within 10 miles of your residence:
500,000 or more
30,000-100,000
1,000-5,000

100,000-500,000
5,000-30,000
1,000 or less
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First round of pilot testing

Second round of pilot testing

Altrozine
Betaxyl
Carpalan
Cherilium
Defonex
Dilactrim
Dolomane
Dopadryl
Donasum
Doyestin
Garicin
Glenestex
Halerol
Joneryx
Karodine
Kentadrin
Kyegran
Lapricin
Marolfan
Orikiax
Peglemar
Phylopsin
Rutalan
Scoplatin
Tabitrol
Tennine
Tracadrin
Tylomex
Upsilonox
Vicolate
Xidafed
Zenopryal

Bendovel
Brinzite
Bromaxx
Caprizine
Chromatan
Coratum
Denonax
Halopax
Dyzoidan
Heptopan
Lanintal
Lobusect
Lynotine
Mavakene
Mentabro
Nocrozin
Nylatrex
Obelzone
Padrysel
Paraclett
Pendian
Polsolop
Raloprox
Ranatar
Remusel
Rinavis
Rybusol
Sportintz
Triferone
Unibide
Winoxyl
Zolatol
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A marketing firm is attempting to identify names for new prescription drugs. Please rate
the following prospective names based on whether you think they would be “excellent”
or “poor” drug names. Please circle the number along the scale that best represents your
opinion.
Altrozine
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

Betaxyl

Carpalan

Cherilium
Poor
1

2

3

4

5

Defonex
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

6

Excellent
7

Dilactrim

Dolomane

Donasum

Dopadryl
Poor
1

2

3

4

5

Doyestin
Poor
1

2

3

4
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5

Garicin
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

Glenestex

Halerol
Poor
1

2

3

4

5

Joneryx
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

Karodine

Kentadrin

Kyegran

Lapricin
Poor
1

2

3

4

5

Marolfan
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Orikiax

Peglemar
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Phylopsin
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

Rutalan

Scoplatin
Poor
1

2

3

4

5

Tabitrol
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

6

Excellent
7

Tennine

Tracadrin

Tylomex

Upsilonox
Poor
1

2

3

4

5

Vicolate
Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Poor
1

2

3

4

5

6

Excellent
7

Xidafed

Zenopryal
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APPENDIX E
EXAMPLE OF FIRST DRUG NAME PAIRINGS
PREFERENCE SURVEY
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A marketing firm is attempting to identify names for new prescription drugs. Please circle
the prospective drug name from each pair you prefer or think is the best name. In other
words, please circle which of these drug names you think is the better name. If you have
no favorite between the two drug names, please circle “No preference.”
Tabitrol

Tylomex

No preference

Altrozine

Lapricin

No preference

Tracadrin

Zenopryal

No preference

Dilactrim

Phylopsin

No preference

Defonex

Xidafed

No preference

Vicolate

Betaxyl

No preference

Karodine

Glenestex

No preference

Kentadrin

Dolomane

No preference

Garicin

Halerol

No preference

Rutalan

Dopadryl

No preference

Scoplatin

Tennine

No preference

Marolfan

Doyestin

No preference

Upsilonox

Cherilium

No preference

Donasum

Carpalan

No preference
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Kyegran

Peglemar

No preference

Joneryx

Orikiax

No preference
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1

APPENDIX F
SETS OF SELECTED DRUG NAME PAIRINGS

147

First round of pilot testing
Drug name pairings
Marolfan
Kentadrin
Garicin
Tabitrol
Defonex
Dilactrim
Karodine
Altrozine
Scoplatin
Donasum

chi-square values
Doyestin
Glenestex
Carpalan
Lapricin
Betaxyl
Phylopsin
Tylomex
Xidafed
Tennine
Cherilium

1.000
1.000
1.000
1.000
1.000
.827
.827
.819
.796
.637

Second round of pilot testing
Drug name pairings
Lynotine
Winoxyl
Ranatar
Halopax
Bendovel
Mentabro
Heptopan
Brinzite
Rinavis
Bromaxx

chi-square values
Raloprox
Pendian
Paraclett
Caprizine
Nocrozin
Polsolop
Coratum
Chromatan
Padrysel
Nylatrex
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1.000
1.000
1.000
1.000
.827
.827
.808
.796
.670
.637

APPENDIX G
LISTING OF EMOTIONAL WORDS
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Word

Valence
Mean (SD)

Arousal
Mean (SD)

Afraid
Anguished
Anxious
Confused
Crushed
Defeated
Discouraged
Disturbed
Embarrassed
Fearful
Frustrated
Guilty
Horrified
Irritated
Neglected
Nervous
Overwhelmed
Panicked
Stressed
Troubled

2.00 (1.28)
2.12 (1.56)
4.81 (1.98)
3.21 (1.51)
2.21 (1.74)
2.34 (1.66)
3.00 (2.16)
3.66 (2.00)
3.03 (1.85)
2.25 (1.18)
2.48 (1.64)
2.63 (1.98)
2.76 (2.25)
3.11 (1.67)
2.63 (1.64)
3.29 (1.47)
4.19 (2.61)
3.12 (1.84)
2.09 (1.41)
2.17 (1.21)

6.67 (2.54)
5.33 (2.69)
6.92 (1.81)
6.03 (1.88)
5.52 (2.87)
5.09 (3.00)
4.53 (2.11)
5.80 (2.39)
5.87 (2.55)
6.33 (2.28)
5.61 (2.76)
6.04 (2.76)
7.21 (2.14)
5.76 (2.15)
4.83 (2.31)
6.59 (2.07)
7.00 (2.37)
7.02 (2.02)
7.45 (2.38)
5.94 (2.36)
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APPENDIX H
EXAMPLE OF FIRST SET OF MEDICAL CONDITION
VIGNETTES

151

David has not been feeling well for the past few months. He has noticed some changes in
his bowel movements and bleeding. He was diagnosed with colon cancer after meeting
and talking with his physician. His family is crushed by his diagnosis, but encouraged
that it was found early. David is learning all he can about his condition and trying to stay
upbeat.

Thomas has been experiencing some slight physical discomfort. He has been urinating
less than normal and feeling sick to his stomach lately. He was informed, after an exam,
that he has signs of kidney disease. His family is frustrated because there is not much
they can do to help. Thomas is convinced he can continue to live a full life.

William has not felt this bad in some time. He has noticed irregular heartbeats along with
feelings of weakness and dizziness in the past few months. His physician recently told
him that he has signs of heart disease. His family is stressed by this news and wants to
help in any way they can. William is trying to rest more and keep his activity level to a
minimum.

Jennifer has had a change in her personality. She was informed that she was going
through some depression after discussing her thoughts and feelings with a health
professional. She has felt sad and hopeless most days at some point and experienced
some weight loss. Her family is afraid of how this problem might affect her life. Jennifer
is seeking help and moving forward step by step.

Mary has not been as active the past several weeks. She has experienced a lack of energy
and some weight loss. She found out after a checkup that she has acquired immune
deficiency syndrome. Her family is horrified about her condition. Mary thinks she can
live a mostly normal life, but will need to stay conscious of her overall health.
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Robert has simply not been himself since he started his new job. His level of anxiety is
high and it has consistently caused stress and panic on a daily basis. He often has a racing
heart and feels a loss of control when he is at work. His family is troubled by his
problems and wants to help in any way they can. Robert plans to take a vacation
sometime soon and contemplate his future.

Christopher has been having some lip and mouth problems. In fact, he has been infected
with forms of both cold sores and fever blisters. He has frequently battled a fever, a sore
throat, and swollen lymph glands in his neck. His family is irritated because his problems
do not appear to be getting any better. Christopher hopes he can get rid of his infection
soon.

Donald has lost much of his confidence and poise. He is going through a tough time of
common sexual dysfunction. His desire for and interest in sexual activity has decreased
the past few months because of both physical and psychological causes. His family is
embarrassed to talk with him about his problem due to the nature of it. Donald is looking
for a few good friends to lean on at the moment.

Patricia has not at all been herself lately. She has been becoming lost in places she knows
well and getting very confused about time, people, and places. She was recently told she
has the beginning stages of Alzheimer’s disease. Her family feels overwhelmed by her
condition because they do not know what to do. Patricia is taking it one day at a time and
hoping for the best.

James has not been enjoying eating the past few months. His physician suggested he has
been experiencing heartburn and acid reflux following meals. He has had some chest pain
and burning in his throat. His family is fearful that his condition will make eating less
enjoyable. James hopes that a change in his diet will help improve his condition.
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APPENDIX I
LISTS OF MEDICAL CONDITIONS
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Older adults
Advertisements and vignettes
Alzheimer’s disease (dementia)
Arthritis (joint and muscle pain)
Cardiovascular disease (heart attack/heart disease/congestive heart failure)
Cholesterol
Emphysema
Glaucoma
Lung cancer
Osteoporosis
Overactive bladder
Skin cancer (melanoma)
Vignettes only
Colon cancer
Hypertension (high blood pressure)
Kidney disease
Parkinson’s disease
Sexual dysfunction
Older/younger adults
Advertisements and vignettes
Acid reflux (heartburn)
Allergies
Anxiety (stress/panic)
Asthma
Depression
Fungal nail infection
Headaches (migraines)
Irritable bowel syndrome
Skin problems (acne)
Sleep problems (insomnia)
Vignettes only
Acquired immune deficiency syndrome
Chronic fatigue syndrome
Kidney stones
Lip and mouth problems (cold sores/fever blisters)
Stomach problems (ulcers)
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APPENDIX J
SAMPLE PRESCRIPTION DRUG ADVERTISEMENTS
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157

158

159

160
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APPENDIX K
DRUG ADVERTISEMENT RATINGS SURVEY

162

The set of prescription drug advertisements you are about to see are considered to be
works in progress. In other words, these ads are potential ads that might be used later as
an actual ad. For each drug advertisement you are about to see, please rate the
appropriateness of the drug NAME for the medical condition.
You will have 15 seconds to rate the appropriateness of the drug name for the medical
condition in each ad.
Advertisement 1
1
2
Not at all
Not very
appropriate appropriate

3
Fairly
appropriate

4
Very
appropriate

5
Extremely
appropriate

Advertisement 2
1
2
Not at all
Not very
appropriate appropriate

3
Fairly
appropriate

4
Very
appropriate

5
Extremely
appropriate

Advertisement 3
1
2
Not at all
Not very
appropriate appropriate

3
Fairly
appropriate

4
Very
appropriate

5
Extremely
appropriate

Advertisement 4
1
2
Not at all
Not very
appropriate appropriate

3
Fairly
appropriate

4
Very
appropriate

5
Extremely
appropriate

Advertisement 5
1
2
Not at all
Not very
appropriate appropriate

3
Fairly
appropriate

4
Very
appropriate

5
Extremely
appropriate
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APPENDIX L
INDIRECT TEST OF MEMORY
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Please circle the drug name from each pair below that you think is the better drug name.

1. Paraclett

Ranatar

2. Padrysel

Rinavis

3. Tylomex

Karodine

4. Raloprox

Lynotine

5. Marolfan

Doyestin

6. Garicin

Carpalan

7. Defonex

Betaxyl

8. Coratum

Heptopan

9. Bendovel

Nocrozin

10. Scoplatin

Tennine
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APPENDIX M
DIRECT TEST OF MEMORY
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Please circle the drug name from each pair below that you recall or remember studying in
the advertisements.

1. Lapricin

Tabitrol

2. Donasum

Cherilium

3. Xidafed

Altrozine

4. Mentabro

Polsolop

5. Dilactrim

Phylopsin

6. Pendian

Winoxyl

7. Halopax

Caprizine

8. Chromatan

Brinzite

9. Kentadrin

Glenestex

10. Nylatrex

Bromaxx
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APPENDIX N
SHIPLEY VOCABULARY TEST

168

On the test below, the first word of each line is printed in CAPITAL LETTERS. Opposite
it are four other words. CIRCLE the one word which means the same thing, or most
nearly the same thing, as the first word. A sample has been worked out for you. If you
don't know, guess. Be sure to circle the one word on each line which means the same
thing as the first word.
sample:
LARGE

red

big

silent

wet

1.

TALK

draw

eat

speak

sleep

2.

PARDON

forgive

pound

divide

tell

3.

REMEMBER

swim

recall

number

defy

4.

HIDEOUS

silvery

tilted

younger

dreadful

5.

EVIDENT

green

obvious

skeptical

afraid
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APPENDIX O
STATE-TRAIT ANXIETY INVENTORY

170

A number of statements which people have used to describe themselves are given below.
Read each statement and then circle the appropriate number to the right of the statement
to indicate how you feel right now, that is, at this moment. There are no right or wrong
answers. Do not spend too much time on any one statement but give the answer which
seems to describe your present feelings best.
NOT AT
ALL

SOMEWHAT

MODERATELY
SO

VERY MUCH
SO

1. I feel calm ..........................................................................................................................
1
2
3
4
2. I feel secure ........................................................................................................................
1
2
3
4
3. I am tense ...........................................................................................................................
1
2
3
4

A number of statements which people have used to describe
themselves are given below. Read each statement and then circle the
appropriate number to the right of the statement to indicate how you
generally feel.
ALMOST
NEVER

SOMETIMES

OFTEN

ALMOST
ALWAYS

21. I feel pleasant ...................................................................................................................
1
2
3
4
22. I feel nervous and restless ................................................................................................
1
2
3
4
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APPENDIX P
MINI-MENTAL STATE EXAMINATION

172

The next series of questions are designed to measure you mental abilities related to
memory and arithmetic. Some of the questions may seem easy, some may seem hard.
Just do the best you can.
1a. What year is it?

_______

2a. What state are we in?

_______

3.

Now I am going to name three objects. When I finish I would like
you to repeat them back to me. Ready? The objects are penny,
apple, and table. (PAUSE) Now repeat them back to me.
PENNY

4.

APPLE

TABLE

Now I will ask you to complete a counting exercise. Please begin
counting with 100 and count backwards by 7s. Keep going until I
ask you to stop.
93, 86, 79, 72, 65

___ ___ ___ ___ ___
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APPENDIX Q
MEDICAL CONDITIONS SURVEY
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Please indicate any medical conditions you currently have or have experienced in the last
5 years by circling Y for yes and N for no.
Acid reflux Y
(heartburn)

N

Hypertension Y N
(high blood pressure)

Acquired immune deficiency syndrome Y
Allergies Y

N

N

Irritable bowel syndrome Y
Kidney disease Y

Alzheimer’s disease Y
(dementia)

N

Kidney stones Y

N
N

Lip and mouth problems Y
(cold sores/fever blisters)

Anxiety Y N
(stress/panic)

Lung cancer Y

N

Arthritis Y N
(joint and muscle pain)

Osteoporosis Y

N

Asthma Y

Overactive bladder Y

N

Parkinson’s disease Y
Cardiovascular diseases Y N
(heart attack/heart disease/congestive heart failure)
Sexual dysfunction Y
High cholesterol Y N
Skin cancer Y N
Chronic fatigue syndrome Y N
(melanoma)

N

N

Colon cancer Y
Depression Y

Skin problems Y
(acne)

N

N

N

N

N

N

Emphysema Y

Sleep problems Y
(insomnia)

N

Fungal nail infection Y
Glaucoma Y

N

Headaches Y
(migraines)

N

N

N

Stomach problems Y
(ulcers)

N

List any other conditions:
______________________________
______________________________
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Please circle your responses.
1. How you would rate your health:
poor

fair

good

excellent

2. Do you have any chronic health conditions? (Chronic conditions are long-lasting
conditions such as asthma, cancer, or heart disease.)
yes

no

If yes, how many? _____
Please list these conditions:_________________________________________________
3. Are you taking any prescription medications?
yes

no

In yes, how many? _____
Please list these medications:________________________________________________
4. Have you had any serious illnesses in the last 5 years?
yes

no

If yes, how many? _____
Please list these illnesses:___________________________________________________
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APPENDIX R
DRUG ADVERTISEMENT EVALUATION
JUDGMENTS SURVEY

177

Please tell us how well you think each of the words listed below describes all of the ads,
on average, you have just seen by circling the number that best represents your thoughts.
We are interested in your thoughts about all of the ads and how well you think the word
describes them.

Believable
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

For me
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Informative
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Interesting
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Irritating
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Meaningful to me
1
2
Not at all
Not very
well
well

3
Fairly
well

4
Very
well

5
Extremely
well

Phony
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Ridiculous
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well
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Terrible
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Valuable
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Worth remembering
1
2
Not at all
Not very
well
well

3
Fairly
well

4
Very
well

5
Extremely
well

Convincing
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Important to me
1
2
Not at all
Not very
well
well

3
Fairly
well

4
Very
well

5
Extremely
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Realistic situation
1
2
Not at all
Not very
well
well

3
Fairly
well

4
Very
well

5
Extremely
well

Original
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Intelligent
1
Not at all
well

2
Not very
well

3
Fairly
well

4
Very
well

5
Extremely
well

Stupid
1
Not at all
well

179

Makes me want to buy
1
2
Not at all
Not very
well
well

3
Fairly
well
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4
Very
well

5
Extremely
well

APPENDIX S
DIAGRAM OF THE EXPERIMENTAL SEQUENCE
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Consent form
Ļ
Demographic survey
Ļ
First set of vignettes
Ļ
Drug advertisement ratings survey
Ļ
First part of Shipley Vocabulary Test
Ļ
Indirect test of memory
Ļ
Second set of vignettes
Ļ
Drug advertisement study exercise
Ļ
Second part of Shipley Vocabulary Test
Ļ
Direct test of memory
Ļ
State-Trait Anxiety Inventory
Ļ
Medical conditions survey
Ļ
Drug advertisement evaluation judgments survey
Ļ
Mini-Mental State Examination
Ļ
Debriefing form
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APPENDIX T
DEBRIEFING FORM
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Debriefing Statement
Perceptions of Potential Prescription Drug Advertisements
Mississippi State, Mississippi 39762
Ty Abernathy, Mississippi State University
Dr. Carolyn Adams-Price, Mississippi State University

(662) 325-0595
(662) 325-7658

The purpose of this experiment is to examine perceptions of potential prescription drug
advertisements, and to assess the potential impact of the ads on viewers. You have just
participated in an experiment designed to explore the relationship between several
cognitive performance factors and processes, such as memory, intelligence, and anxiety.
Your input will enable the researchers to better determine the roles these factors and
processes play in everyday cognitive functioning, independently and collectively, in both
old and young adults.
The experiment consisted of medical condition vignettes and prescription drug
advertisements containing fictitious information and related implicit and explicit memory
measures. The experiment also consisted of a demographic survey, a cognitive exam, a
vocabulary test, an anxiety inventory, a medical conditions survey, and an ads evaluation
judgments survey. These materials are designed to assess certain cognitive capacities.
The researchers are studying whether drug ads have an effect on memory and cognitive
processing even when a person cannot remember seeing them.
Your participation is greatly appreciated. For further concerns or questions about your
participation in this experiment, please contact the researchers noted above. Thank you
for your participation in this experiment.
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APPENDIX U
INSTITUTIONAL REVIEW BOARD APPROVAL FORM

†
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